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ABSTRACT
Two relatively new techniques by which the pulmonary arteries can be imaged
in life are intravascular ultrasound and magnetic resonance imaging. The main
aim of this thesis is to describe the changes which are detectable on
intravascular ultrasound and magnetic resonance imaging in patients with
pulmonary hypertension and to determine whether these imaging modalities
could be of use for the clinical assessment of the condition.
Intravascular ultrasound was performed in 10 young adults with Eisenmenger's
Syndrome and 4 infants with pulmonary hypertension secondary to a left to
right shunt. Vasodilator studies were performed in 5 of the patients with
Eisenmenger's. The vessel wall appeared as a single echogenic layer in all
patients, making it difficult to define or measure medial thickness with
certainty. Morphological changes of intimal hypertrophy and atherosclerosis
were evident in patients with Eisenmenger's whereas in the infants the intima
appeared thin and smooth, typical of normal artery. The technique gave
excellent definition of the vessel lumen allowing continuous measurement of
changes in luminal dimensions in response to vasodilators.
MRI of the pulmonary arteries was performed in 11 patients with
Eisenmenger's and 6 normal controls. In patients with pulmonary hypertension
the pulmonary arteries were found to be dilated with reduced distensibility
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when compared with normals. Calculations of Qp:Qs by MRI in patients with
systemic to pulmonary shunts and pulmonary hypertension did not correlate
well with values from cardiac catheterisation in all patients.
As intravascular and magnetic resonance imaging are confined to the elastic
pulmonary arteries, quantitative morphological studies were peformed on 24
post mortem specimens of lungs from patients who had died with pulmonary
hypertension to determine whether there was any correlation between changes
in the elastic pulmonary arteries and severity of pulmonary vascular disease.
When compared with normals there was medial thickening in those with
pulmonary hypertension but this was of an insufficient degree to be detectable
by current ultrasound catheters. There was no correlation between degree of
medial thickening in the elastic pulmonary arteries and severity of pulmonary
vascular disease but intimal thickening and atherosclerosis were evident in
those with more advanced disease.
In conclusion, magnetic resonance imaging was found to have limited role in the
assesssment of pulmonary hypertension but with new technical developments
could become a non-invasive method of studying pulmonary hypertension in the
future. The morphological changes detectable by intravascular ultrasound
tend to be in severe disease only but the technique provides a unique method
of studying pulmonary vascular reactivity in life.
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SUMMARY
A perplexing problem in congenital heart disease is that of pulmonary
hypertension and the development of pulmonary vascular disease in patients
with left to right shunts. First, the pathogenesis and physiology of pulmonary
vascular disease is poorly understood and most of our understanding of the
development and progression of the disease has come from the study of lung
biospies. Second, the accurate assessment of the severity and reversibility of
pulmonary vascular disease in life is limited and largely inferred from
measurements made by methods such as Doppler or angiography. Third, our
ability to modify the disease remains poor.
The study of the pathophysiology of pulmonary hypertensive vessels in life has
been hindered by difficulty in imaging the vessels. The main method of imaging
the pulmonary vessels in life remains angiography which merely provides a
sillouette of the pulmonary tree.
Pulmonary vascular disease is essentially a disease of the peripheral vessels
but post mortem studies show that hypertensive induced intimal and medial
hypertrophy also occur in the larger elastic pulmonary arteries as well as in the
peripheral vessels. Two relatively new techniques by which the elastic
pulmonary arteries can be imaged in life are intravascular ultrasound and
magnetic resonance imaging. Intravascular ultrasound images the vessel wall
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layers from within the vessel lumen, theoretically allowing imaging of changes in
vessel wall morphology as well as assessment of vessel physiology. Magnetic
resonance imaging has been established as an important clinical tool in the
diagnosis of congenital heart disease, particularly for assessing the pulmonary
arteries. Recent advances in magnetic resonance techniques have made it
possible to evaluate vessel pulsatilty and flow, potentially providing a
noninvasive means of studying pulmonary arterial pathophysiology in life.
The main aim of this thesis was to describe the changes which are detectable
on intravascular ultrasound and magnetic resonance imaging in patients with
pulmonary hypertension and to determine whether these imaging modalities
could be of use in the clinical assessment of the condition.
Intravascular ultrasound was performed in 10 young adults with Eisenmenger's
Syndrome and 4 infants with pulmonary hypertension secondary to a left to
right shunt. Vasodilator studies were performed in 5 of the patients with
Eisenmenger's. On intravascular imaging, the vessel wail appeared as a single
echogenic layer in all patients, making it impossible to define or measure medial
thickness with certainty. Morphological changes of intimal hypertrophy and
atherosclerosis were evident in patients with Eisenmenger's, whereas in the
infants the intima appeared thin and smooth, typical of normal artery.
Intravascular ultrasound was found to give excellent definition of the vessel
lumen allowing continuous measurement of changes in luminal dimensions in
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response to vasodilators.
MRI of the pulmonary arteries was performed in 11 patients with
Eisenmenger's and in 6 normal controls. In patients with pulmonary
hypertension the pulmonary arteries were found to be dilated with reduced
distensibilty when compared with normals. Calculations of Qp:Qs by MRI
correlated well with values at catheterisation in only 5 out of 7 patients with
systemic to pulmonary shunts and pulmonary hypertension.
In order to determine the relation between morphological changes in vessels
amenable to intravascular ultrasound and severity of pulmonary vascular
disease, quantitative morphological studies were peformed on 24 post mortem
specimens of elastic pulmonary arteries from patients who had died with
pulmonary hypertension. When compared with normals there was medial
thickening of the elastic pulmonary arteries but this was of an insufficient
degree to be detectable by current intravascular transducers. There was no
correlation between degree of medial thickening and severity of pulmonary
vascular disease. Intimal thickening and atherosclerosis were evident in those
with more advanced disease.
In conclusion, magnetic resonance imaging has little role in the clinical
assesssment of pulmonary hypertension at present but with new technical
developments could become a non-invasive method of studying pulmonary
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hypertension in the future. The morphological changes detectable by
intravascular ultrasound tend to be in severe disease only but the technique





Normal Pulmonary Arterial Pressures
Pulmonary hypertension simply refers to an elevation in pulmonary arterial
pressures above the normal. In the adult, normal pulmonary arterial pressure
is around 1 5-30mmHg systolic and 5-10mmHg diastolic, with a mean of
approximately 15mmHg. In the foetus, pulmonary arterial pressures are
considerably higher than in the newborn or adult. 1 Pulmonary arterial
resistance falls dramatically at birth with the onset of ventilation. Immediately
following birth, pulmonary arterial pressure is equal to systemic but within
hours to days the pressure falls to near normal adult levels and usually within
two weeks mean pulmonary arterial pressure has fallen to approximately
1 5mmHg,2 although is slightly higher (around 25mmHg) at high altitudes.3
The Morphology of the pulmonary arteries
Although pulmonary arterial pressures fall relatively quickly following birth, it
takes longer for the morphology of the pulmonary vessels to regress to the
appearances seen in adult vessels.4 Morphologically the pulmonary arterial
tree can be divided into three types of vessel; elastic pulmonary arteries,
muscular pulmonary arteries and pulmonary arterioles. The elastic pulmonary
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arteries include the pulmonary trunk and main pulmonary arteries. They are
distinguished by their relatively thin media which has scant smooth muscle and
is made mainly of elastin arranged in a loose network. The elastic pulmonary
arteries generally extend to the 7th generation in the pulmonary tree (the
segmental artery is considered as the first generation).5 The muscular
pulmonary arteries are smaller (generally less than 500pm in the adult) and
are distinguished by a media which consists mostly of smooth muscle with little
elastin. The arterioles are thin-walled vessels, consisting of a single layer of
endothelial cells on a basal lamina. Pulmonary arterioles are the smallest
vessels in the arterial tree and accompany the alveoli. Under normal
conditions they have no medial layer.
Changes in pulmonary arterial morphology following birth
At birth the media of the pulmonary trunk has a configuration similar to that
of the aorta, with a thick medial muscular coat and a dense network of
interlocking parallel elastic fibrils (Fig 1). As pulmonary arterial pressure falls,
the media of the pulmonary trunk becomes thinner and the elastic fibres lose
their parallel configuration to become disarrayed in a loose network.6,i
The media of the muscular pulmonary arteries also is significantly thicker in the
newborn than in the adult. The percentage of medial thickness to total vessel
diameter in the newborn approaches 20% but by age two months has
decreased to near adult values of 5-10%.67
11
Figure 1.
Media of the pulmonary Trunk (x 25) (Elastin Van Giesen)
The media has a thick medial muscular coat with a dense network of
interlocking parallel elastic fibrils.
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Causes of pulmonary hypertension
Causes of pulmonary hypertension are listed in table A.
There are several causes of elevated pulmonary arterial pressures which can
be divided into three broad categories:
1. Hyperdynamic pulmonary hypertension, secondary to increased pulmonary
blood flow, e.g from a left to right shunt.
2. Passive pulmonary hypertension, secondary to increased back pressure
from elevated pulmonary venous pressure or left atrial pressure, e.g mitral
stenosis.
3. Reactive pulmonary hypertension secondary to an increase in pulmonary
vascular resistance resulting from constriction of the muscular pulmonary
arteries, e.g primary pulmonary hypertension.
It is rare to find any 'mechanism' of pulmonary hypertension in isolation. For
example, in patients with left to right shunts, there are elements of
hyperdynamic and reactive pulmonary hypertension and if left heart failure
develops, also an element of passive pulmonary hypertension.
1 3
Table A










Atrial septal defect (rarely in childhood)
Total anomalous pulmonary venous connection (unobstructed)
Transposition of the great arteries
Truncus arteriosus
Common or single ventricle
High output states
Carcinoid syndrome








Elevated pressures in the pulmonary circulation have a deleterious effect on the
pulmonary resistance vessels which can result in pulmonary vascular disease.
Pulmonary vascular disease appears to develop most rapidly when the
pulmonary circulation is subjected both to increased blood flow and elevated
pressure, such as when there is a large ventricular septal defect, patent
arterial duct, aortopulmonary window, truncus arteriosus or transposition of
the great arteries.8
Pathology of pulmonary vascular disease
The major changes of pulmonary vascular disease occur in the small resistance
vesels, i.e. the arterioles and muscular pulmonary arteries. In the initial stages
there is thickening of the media of the muscular pulmonary arteries with
extension of muscle distally into the pulmonary arterioles (Fig 2). This is
followed by cellular intimal hypertrophy (Fig 3). As the disease progresses,
cellular intimal proliferation gives way to intimal fibrosis, the vessel walls lose
their elasticity and complex vascular lesions develop in the form of plexiform,
angiomatoid, and cavernous lesions (Fig 4). The elevated pulmonary
pressures result in chronic dilatation of these vessels, with eventual rupture of
the thin walled arteriolar sacs, haemorrhage into alveoli and pulmonary
haemosiderosis (Fig 5). The end result is a necrotising arteritis.9
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Figure 2.
Grade 1 pulmonary vascular disease (x 100) (Elastin Van Giesen)
There is medial thickening in the muscular pulmonary arteries.
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Figure 3.
Grade 2 pulmonary vascular disease, (x 200) (Haematoxylin and Eosin)
There is cellular intimal hypertrophy (arrow).
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Figure 4.
Grade 4 pulmonary vascular disease, (x 100) (Haematoxylin and Eosin)
A Plexiform complex vascular lesion is shown.
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Figure 5.
End-stage pulmonary vascular disease (x200) (Haematoxylin and Eosin)
There is rupture of thin-walled arteriolar sacs, haemorrhage into alveoli and
pulmonary haemosiderosis.
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Morphology of the pulmonary trunk in pulmonary hypertension
Morphological changes are also evident in the pulmonary trunk in pulmonary
hypertension. If pulmonary arterial pressures remain elevated after birth, the
pulmonary trunk retains its thick muscular media as well as the parallel
arrangement of the elastic fibres similar to that of the aorta, i.e. so-called
'aortification' of the pulmonary trunk.6.7 If, however, pulmonary hypertension
resolves following birth but then recurs later in life, the pulmonary trunk
develops a thick medial muscular coat but the elastic fibres have had time to
become disarrayed and have the normal 'adult' appearance.
Reversibilty of pulmonary vascular disease
One of the most crucial factors to be considered in the management of
patients with left to right shunts is the progresssive nature of pulmonary
vascular disease. If a defect is left uncorrected pathological changes can
progress and become so advanced as to become irreversible. Closure of the
defect at this stage can result in accelerated right heart failure. Assessment
of the severity and reversibilty of pulmonary vascular disease is therefore of
vital importance especially in the management of the older infant or child with a
left to right shunt.
Heath Edwards grades
In an attempt to define the histological changes which correlate with clinically
irreversible disease, Heath and Edwards in 1958, graded the histological
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changes of pulmonary vascular disease from 1 to 6 according to increasing
severity (Table B).9 They found that the main histological features correlating
with irreversibility were development of the complex vascular lesions and vessel
dilatation (grade 4 in their grading system). The complex vascular lesions
probably develop as the result of repeated microthrombosis and
recanalisation of the arterioles. These plexiform lesions are proximal to most
of the alveolar capillary bed and have a very high resistance to blood flow.
The rate at which pulmonary vascular disease develops may differ according
to type of cardiac anomaly.s Whereas in an uncorrected large ventricular
septal defect, irreversible vascular lesions may not develop until after the first
few years of life, in infants with transposition of the great arteries and a
ventricular septal defect, irreversible changes may develop as early as 2
months and almost always by 2 years. The reasons for this are unclear. In
addition there are some patients with septal defects in whom pulmonary
vascular resistance appears never to fall after birth and who never develop
cardiac failure.io
Ventricular Septal Defects and Pulmonary Hypertension
Ventricular septal defects are the commonest of congenital heart lesions and
can be used as a model to consider the development of pulmonary
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Table B
HEATH-EDWARDS GRADES OF PULMONARY VASCULAR DISEASE
Grade 7
Thickening of the adventitia and media of the muscular pulmonary arteries
with extension of muscle distally into the pulmonary arterioles which do not
normally have a muscular layer.
Grade 2
Medial thickening as observed in grade 1 plus cellular intimal proliferation.
In some cases the cellular intimal proliferation can be so marked as to
occlude the arteriolar lumen.
Grade 3
Medial hypertrophy as observed in grade 1. The intimal cellular proliferation
observed in grade 2 gives way to fibrosis. The changes of medial and
intimal hypertrophy begin to extend into the larger muscular pulmonary
arteries (1 00-500/vm).
Grade 4
As a result of fibrosis the vessel intima loses its elasticity and complex
vascular changes begin to develop in the form of plexiform, angiomatoid,
and cavernous lesions.
Grade 5
At this stage the emphasis in histological features shifts from intimal and
medial hypertrophy to vascular dilatation. The pulmonary arterioles and
smallest muscular pulmonary arteries become greatly distended to form
plexiform sacs with fragile walls. Chronic dilatation of the vessels occurs.
Grade 6
As a result of chronic dilatation, there is eventual rupture of the thin walled
arteriolar sacs with haemorrhage into alveoli and pulmonary
haemosiderosis. The end result is a necrotising arteritis.
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vascular disease in individuals with left to right shunts. The development of
pulmonary vascular disease in patients with a ventricular septal defect
depends upon the size of the lesion and individual reactivity of pulmonary
vessels. Approximately 50% of ventricular septal defects will close
spontaneously or become smaller within the first few months or years of life,
n.12 in these patients pulmonary arterial medial thickening resolves and
pulmonary vascular resistance decreases. In infants with large ventricular
septal defects the pulmonary vascular resistance usually falls transiently after
birth, resulting in an increase in left to right shunting and the development of
heart failure. In most of those infants, there is a marked increase in the
muscle mass of the small pulmonary arteries and this is associated with an
increase in pulmonary vascular resistance. 13 If such large defects are left
uncorrected, pulmonary vascular changes can progress.
Eisenmenger Syndrome
When the pulmonary vascular resistance becomes higher than the systemic
vascular resistance there is shunt reversal and the patient becomes cyanosed.
In 1987, Eisenmenger described the case of a patient who had been breathless
and cyanosed since infancy and who died following massive haemoptysis at the
age of 32.14 At postmortem he was found to have a large ventricular septal
defect. Eisenmenger realised that the pulmonary vascular resistance had been
elevated but failed to identify this as the cause of the patient's right to left
shunt and cyanosis. Since Eisenmenger's first case report the term
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'Eisenmenger Complex' has been given to other patients with a ventricular
septal defect and cyanosis secondary to shunt reversal.
In 1958, Paul Wood pointed out that other lesions resulting in left to right
shunts could lead to an elevated pulmonary vascular resistance with eventual
reversal of the shunt and cyanosis.15 He defined such a combination as the
Eisenmenger Syndrome. The natural history of the Eisenmenger Syndrome is
one of increasing cyanosis and ultimately, heart failure. Patients usually survive
to the third decade. Death is often sudden, from haemoptysis or syncope, the
latter presumed to be secondary to arrhythmia or pulmonary hypertensive
crisis. There is no known medical treatment to significantly influence the
pulmonary vascular resistance in these patients. Surgical closure of the
anatomical lesion responsible for the elevated pulmonary vascular resistance
will only result in accelerated death from right heart failure. Cardiopulmonary
transplant is the only therapeutic option currently available.
Clinical features of pulmonary hypertension
Clearly it is important to identify the presence of pulmonary hypertension
before irreversible pulmonary vascular disease develops. The clinical signs of
pulmonary hypertension include a prominent a-wave in the jugular venous pulse,
a palpable right ventricular impulse at the left sternal edge and a loud
pulmonary component of the second sound. A short ejection systolic murmur
may be heard in the pulmonary area due to ejection of blood into the dilated
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pulmonary artery. In some, an early diastolic murmur is audible down the left
sternal border due to functional pulmonary regurgitation. The chest X-ray
typically reveals a prominent right ventricle, a dilated pulmonary artery and
pruning of the small peripheral vessels. On ECG there are peaked p-waves due
to right atrial hypertrophy and tall R waves in V4R and V1, indicative of right
ventricular hypertrophy.
Assessment of pulmonary hypertension and pulmonary vascular
disease
The earliest and most established method of measuring the severity of
pulmonary hypertension is cardiac catheterisation during which pulmonary
arterial pressures can be measured and pulmonary vascular resistance
calculated from the following equation:
Pulmonary vascular resistance =
Pulmonary arterial pressure - left atrial pressure
Pulmonary blood flow
where, Pulmonary blood flow =
Pulmonary oxygen uptake
Pulmonary venous oxygen content - pulmonary arterial oxygen content
Unfortunately the increase in pulmonary vascular resistance does not always
accurately correlate with the severity or reversibilty of pulmonary vascular
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disease which is the most important information required to determine the
feasibilty of surgery. There is some evidence that pulmonary vascular disease
is likely to be reversible if pulmonary vascular resistance is labile and falls
during administration of vasodilators such as Oxygen and Prostacyclin, the
assumption being that if the only structural change in the pulmonary
vasculature is muscle hypertrophy, the circulation should still respond to
vasodilators.^ The ability of this technique to accurately predict the
reversibility of pulmonary vascular disease, however, is poor.
Wedge Angiography
Wedge angiography has been used as a method to improve the correlation
between structural and functional changes. In the normal lung the pulmonary
arteries should taper towards the periphery but in elevated pulmonary
vascular resistance, the vessels taper over a shorter distance (so-called
'pruning'). In a study by Rabinovitch and colleagues in 1 978, the rate of
tapering was found to correlate both with pulmonary haemodynamics at
cardiac catherisation and severity of pulmonary vascular disease at biopsy.i?
The problem with wedge biopsy is that although it identifies patients with
advanced pulmonary vascular disease it cannot differentiate between patients
with less severe stages of diease who are potentially operable.
Doppler
The relatively recent introduction of Doppler into clinical cardiology has allowed
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non-invasive estimation of pulmonary arterial pressures from measurement of
tricuspid and pulmonary regurgitant jets. In pulmonary hypertension the
velocity of the regurgitant jets is high. The pressure drop (Pi - P2) across the
tricuspid valve can be calculated if the velocity of the jet (V) is measured in
metres/second and the modified Bernoulli equation applied:is
Pt - P2= WmaxZ
Provided there is no pulmonary artery stenosis the right ventricular pressure
can be assumed to equal pulmonary arterial pressure.is
Right atrial pressure is normally 5-10mmHg. If right atrial pressure is added
to the pressure drop across the tricuspid valve an estimation of right
ventricular systolic pressure and thus systolic pulmonary arterial pressure can
be obtained.20 Likewise by measuring the maximum velocity of the pulmonary
regurgitant jet and applying the Bernoulli equation it is possible to obtain an
estimation of pulmonary diastolic pressure. 21 Unfortunately, not all patients
have measurable tricuspid or pulmonary regurgitation. 22 in addition, Doppler
can only estimate pulmonary arterial pressure and not the severity or
reversibility of pulmonary vascular disease.
Lung Biopsy
The gold standard for assessing the severity of pulmonary vascular disease is
open lung biopsy where the pathological changes of pulmonary vascular
disease can be observed and graded. A major drawback is that surgery is
required and the changes may be patchy so that a single biopsy may not be
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representative of the whole lung.23 in addition, lung biopsy provides limited
information regarding changes in vessel physiology secondary to pulmonary
hypertension.
In-vivo Study of Pulmonary Hypertension
At present there is no satisfactory method of studying pulmonary arterial
morphology and physiology in life. New in-vivo methods of investigating the
pulmonary vessels in pulmonary hypertension would be useful, not only to help
in the clinical assessment of disease but also to improve our understanding of
the pathogenesis and physiology of pulmonary vascular disease and to aid
research into identifying means of modifying the disease.
There are two relatively new imaging techniques which allow dynamic imaging
of the pulmonary vessels; intravascular ultrasound and magnetic resonance
imaging. Initial studies have suggested that these techniques could provide a
means of evaluating pulmonary hypertension in life but to date their use in
patients with pulmonary hypertension has not been established. 24,25
The purpose of this thesis is to evaluate the use of intravascular ultrasound
and magnetic resonance imaging in the study of pulmonary hypertension.
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Aims
The aims of this thesis are as follows:
1. To evaluate the use of intravascular ultrasound as a method of imaging the
morphological changes which occur in pulmonary hypertension.
2. To evaluate the use of intravascular ultrasound to study the effect of
pulmonary vasodilators in pulmonary hypertension.
3. To describe the changes detectable by MRI of the pulmonary arteries in
pulmonary hypertension.
4. To determine the ability of MRI to measure pulmonary arterial flow and
Qp:Qs in patients with systemic to pulmonary shunts.
5. As intravascular and magnetic resonance imaging are confined to the elastic
pulmonary arteries, to quantify the morphological changes in the elastic
pulmonary arteries in pulmonary hypertension and establish their relation to
the severity of pulmonary vascular disease.
6. To determine whether intravascular ultrasound and MRI could be of clinical





Intravascular ultrasound is not a new concept. It was first described in 1960
by Cieszynski who introduced a single element catheter into the hearts of dogs
to measure cardiac chamber sizes.26 Similar studies were performed by a
number of other researchers27-29 but then interest waned somewhat in the
technique, probably due to the development of transthoracic and
transoesophageal echo. It has only been in the past five to ten years that
there has been renewed interest in intravascular imaging, largely as a result of
the increase in therapeutic intervention of coronary artery disease bringing
with it the need to define as clearly as possible the nature and extent of
atherosclerosis.so
Angiography versus ultrasound
Although angiography is considered the current gold standard for studying
atherosclerosis, the technique only gives a sillouette of the vessel wall. As a
result it may miss early disease, may underestimate the extent of disease and
gives little information regarding plaque type and morphology or the effects of
interventions on the vessel wall.3i,32 intravascular ultrasound, on the other
hand, potentially provides an ideal method for studying atherosclerosis. This is
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because intravascular ultrasound images the vessel from within the vessel
lumen itself, potentially allowing accurate measurement of luminal dimensions,
of plaque size and morphology, of vessel wall morpholgy and also of the
effects of interventions on the vessel wall itself.33,34
Intravascular Ultrasound Catheters
The concept of intravascular imaging is simple, i.e. a cardiac catheter with an
ultrasound transducer built into the tip. Technically, however, such a catheter
is difficult to produce as it must be small, flexible, easy to manipulate, but yet
produce good quality images. It is largely thanks to the pioneering work of
Bom and his colleagues in Rotterdam that we have the ultrasound catheters
that are commercially available today (Fig 6).35 These ultrasound catheters
look very similar to ordinary cardiac catheters and are available in different
sizes, ranging from 3 French (i.e. approximately 1 mm in diameter) to 9 French.
The ultrasound transducer is situated just proximal to the tip. The transducer
itself may be mechanical, consisting of a single element with a rotating mirror,
or be phased array, consisting of a circular array of elements built around the
tip. In the mechanically rotated catheters the drive shaft is found within the
catheter body itself. The non-imaging end connects to an ultrasound machine




Catheter sizes range from 3 French to 9 French and frequency of
transducer from 12.5MHz to 30MFIz. The ultrasound tranducer is situated
just proximal to the tip (arrow), the drive shaft is found within the catheter
body and the non-imaging ends fit onto an ultrasound machine adapted for
use with intravascular imaging.
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The catheters are available in different frequencies; mainly 30MHz, 20MHz and
12.5MHz. The higher the transducer frequency the better the near resolution
but less field of depth. The higher frequency probes, therefore, are most
suited to studying the smaller vessels, whereas the lower frequency catheters
are more suited to studying larger vessels or for intracardiac imaging.36
Intravascular Ultrasound Imaging
The catheters used for the studies described in this thesis were all mechanically
rotated transducers (Mansfield Scientific, Boston USA). Figure 7 shows a
diagramatic representation of such a catheter. To prepare the catheter for
use it is necessary to eliminate the air between the ultrasound transducer and
the catheter wall. This is achieved by injecting water into the port around the
transducer. To ensure all the air is eliminated the catheter tip is twirled several
times. The catheter is then ready for use and is introduced into the patient in
a manner similar to introducing any cardiac catheter. To assist with catheter
guidance and manipulation, some of the ultrasound catheters have a monorail
for use with a guide wire, otherwise they may be introduced through a long
sheath.
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Sonicath® CV Intravascular Ultrasound Cath
Preparation For Use
Transducer Needle
• Fill syringe with sterile water, purge air
• Replace needle with fill guide, purge air
• Insert catheter fully into fill guide
• With catheter tip oriented downward, inject 0.3
• Remove catheter
• Point distal end downward and flick tip
• Rapidly twirl distal 20cm of catheter a few times
O.Scc sterile water
Figure7.
Diagram of an intravascular ultrasound catheter.
Water is injected into the port around the transducer to eliminate air.
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Intravascular Ultrasound of a Muscular Artery
Imaging begins as soon as the ultrasound catheter is introduced into the
patient. Figure 8 shows a typical ultrasound image of a muscular artery.
Characteristically on intravascular imaging of muscular arteries the vessel wall
has a trilayer appearance, consisting of an inner echodense ring, an outer
echodense ring and a middle echolucent ring.37,38 On initial in-vitro histological
studies these three layers were identified as the three histological layers of the
vessel wall, i.e the intima, the media and the adventitia.39,40 it is believed that
it is the elastin within the vessel wall which is echoreflective, thus the media
(which is relatively elastin poor compared to the elastin rich intima and
adventitia) is echolucent.40.4i This theory is supported by the observation that
the walls of elastic arteries, which have a relatively elastin rich media with
scant smooth muscle, tend to appear as a single echodense ring on
intravascular imaging rather than a three layered ring.4i
The precise nature of the trilayer appearance is, however, controversial.
Certainly it is not always seen on ultrasound imaging of muscular arteries in life,
especially in younger patients. Some would argue that the process of tissue
fixation of vessels for in-vitro histological studies alters the ultrasound
characteristics of the vessel walls allowing a trilayer appearance to be seen.42
Others argue that the trilayer apearance seen in life may simply be due to
differences in mobility in different parts of the vessel wall resulting in reflection
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Ultrasound image of a muscular artery (right). The ultrasound catheter is
seen as a small circle within the vessel lumen. The outer white ring is the
vessel wall and is seen here to have the characteristic trilayer appearance.
The middle and left image show an atheromatous plaque.
Ultrasound image of crescentic atheromatous plaque (white arrow). The
vessel wall has a trilayer appearance, consisting of an inner and outer
echodense ring separated by a middle echolucent ring (black arrows).
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explain the observation that the trilayer appearance is more commonly seen in
vessels of older patients or in patients with diseased vessels who are more
likely to have areas of altered compliance in the vessel wall. 44
The precise nature of the trilayer appearance therefore remains controversial
but there is agreement that intravascular ultrasound allows accurate
measurement of luminal dimensions and visualisation of the intimal surface, thus
providing a unique technique for studying atherosclerosis.4^4^
Imaging of Atheroma
Figure 9 shows an intravascular image of an atheromatous plaque. Again the
ultrasound catheter can be seen as a small echodense ring in the middle of the
vessel lumen. The vessel wall is the outer white ring and in this image is seen as
a trilayered structure, consisting of inner and outer echodense rings separated
by a middle echolucent ring. These three layers may represent the three layers
of the vessel wall. In addition a rather homogenous crescentic shaped mass
can be seen impinging upon the vessel lumen and this is an atherosclerotic
plaque. In this instance the plaque appears to consist of fibro-fatty material
with very little calcium. It can be appreciated that with intravascular
ultrasound it is possible to obtain accurate measurements of luminal diameter,
plaque size, residual luminal diameter and percent stenosis as well as
determine plaque type and morphology.
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There have been numerous studies evaluating the use of intravascular
ultrasound in assessing atherosclerosis and in 1991 it was estimated that over
140 centres throughout the United States and Europe were using the technique
for clinical applications.47 it is now established that with intravascular
ultrasound it is possible to detect early disease which may be missed by
angiography^ to measure the extent and severity of atherosclerosis often
more accurately than by angiography;49 and to evaluate the effects of
interventions on atheromatous plaques and the adjacent wall which may not
be appreciated by angiography.so As a result some enthusiasts have
suggested that the technique should replace angiography as the gold standard
for studying atherosclerosis.5i
Whereas it is unlikely that intravascular ultrasound will replace angiography for
the routine investigation of coronary artery disease, it is proving to be a useful
adjunct to angiography in assessing plaque regression,52 determining the
suitability of different lesions for intervention, evaluating the effects of
intervention,53 and clarifying diagnosis in cases where coronary artery status
remains unclear despite angiography.49
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INTRAVASCULAR ULTRASOUND IN CONGENITAL HEART DISEASE
In contrast to the numerous studies in coronary artery disease there have
been very few studies of the use of intravascular ultrasound in congenital heart
disease. Most of the results of these studies have been published only in
abstract form which probably witnesses to the rather disappointing findings.
There are, however, four potential areas of application for intravascular




3. Diseases of the pulmonary arteries
4. Endothelial function and vascular reactivity.
1 .Intracardiac Imaging
The first 2-dimensional intracardiac ultrasound imaging was performed in the
hearts of dogs using a 5 MHz transoesophageal probe.54 Not surprisingly,
using this probe it was possible to obtain excellent images of intracardiac
structures, including a four chamber view and clear images of the valves, the
outflow tracts and the coronary sinus. This raised hopes that intracardiac
imaging held potential for guiding interventions within the heart, including
closure of septal defects and radiofrequency ablations.55,56
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Obviously it is not feasible to use transoesphageal probes in the hearts of
humans, and therefore 20 MHz and 12.5 MHz ultrasound catheters have been
employed.57,58 These studies report that although it is possible to image
intracardiac structures there are problems with limited depth of field and
difficulty in maintaining stability of the catheter. 24,59
During the period of research for this thesis, intracardiac ultrasound was
performed in 12 young adults (aged 16-35) with congenital heart disease who
were undergoing diagnostic catheterisation. 10 of the young adults were also
undergoing pulmonary intravascular imaging and the intracardiac studies were
performed at the same time. (See Chapter 3 and Table C, p66 ) The other 2
patients comprised a 19 year-old male with pulmonary arterial stenosis
following previous repair of Tetralogy of Fallot and a 1 6-year old female with
pulmonary atresia and ventricular septal defect. Informed consent was
obtained from the patients prior to commencing the studies. 6 French,
12.5MHz mechanically rotated ultrasound catheters (Mansfield Scientific) were
used for the intracardiac studies. Following the diagnostic catheter procedure,
the femoral venous sheath was exchanged for an 8 French, long biopsy sheath.
The biopsy sheath was introduced into the right atrium and the ultrasound
catheter passed through the sheath and into the heart. Images were recorded
with the catheter in the ventricle and while the catheter was being withdrawn
through the tricuspid valve into the right atrium and inferior vena cava. The
procedure was uncomplicated in all patients.
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In all patients, despite the long sheath, it was difficult to keep the catheter
stable within the chambers of the heart; the catheter tended to move widely
to and fro with each heart beat, distorting images. Due to the limited depth of
field of the transducer it was not possible to image the cardiac chambers or
valves in their entirety.
Fig 10 shows an intracardiac ultrasound image of an atrioventricular septal
defect. The catheter can be seen in the chamber of the right ventricle, the
outer echogenic 'ring' is the surrounding myocardium and the gap in the
myocardium represents part of the atrioventricular septal defect. The ventricle
could not be imaged in its entirety.
Fig 11 shows an intracardiac image of the right ventricular outflow tract in a
19 year old male with a previous repair of Tetralogy of Fallot. The
transannular patch is brightly echogenic. One of the leaflets of the pulmonary




Intracardiac Image of an atrioventricular septal defect.
The catheter can be seen in the chamber of the ventricle. The outer white
'ring' is the myocardium (m) and the gap in the myocardium (g) represents
part of the atrioventricular septal defect.
Intracardiac image of the right ventricular outflow tract.
The transannular patch is brightly echogenic and calcified. One of the
leaflets of the pulmonary valve can be seen as a thin echogenic line (arrow).
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On analysis of the small group of patients studied, intravascular ultrasound
proved more expensive, more invasive, less readily available, had less field of
depth, produced poorer images and was more difficult to manipulate when
compared with transthoracic and transoesophageal echocardiography for
imaging of congenital heart defects. Certainly at present, it is difficult to see a
clear role for intracardiac imaging of structural defects.
2. Vascular Interventions
Over the past decade, there has been rapid development of techniques and
applications for interventional catheterisation. The main application has been in
the management of atheroma which may be treated by techniques including
angioplasty, atherectomy or stenting. In Paediatric Cardiology, atheroma is
rarely a problem, but vessel stenoses, such as those which occur in the
pulmonary arteries or aorta may be improved by angioplasty or stenting.60,61
Intravascular Ultrasound to Monitor Interventions of Atheroma
Intravascular ultrasound provides a unique method of monitoring the effect of
catheter interventions on the vessel wall in life. Prior to intervention, the
technique provides information regarding the severity of stenosis, the nature of
the stenosis and the suitability for different types of intervention. Following
intervention, the success of the procedure, the creation of any intimal tearing
and the development of complications can be evaluated. Finally, perhaps if we
understood more fully the nature of the lesion inflicted on the vessel wall, the
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risk of restenosis could be predicted.62,63
There have been many studies of the use of intravascular ultrasound in
monitoring interventions of atherosclerosis.53,62-65 Fig. 1 2 shows an
atheromatous plaque as visualised by angiography and intravascular
ultrasound. Prior to angioplasty the narrowing caused by the plaque can be
appreciated on angiography but with intravascular ultrasound information can
also be obtained about plaque morphology and percent stenosis. Following
angioplasty, an improvement in luminal diameter can be seen on angiography,
but with intravascular imaging it is possible to determine the effects on the
atheromatous plaque.
Stent Deployment
Perhaps the most useful application of intravascular ultrasound in interventional
catheterisation has been in assessing the deployment of stents. In 1994,
Colombo and colleagues demonstrated that over 80% of stents may not be
fully deployed when visualised by intravascular ultrasound and that inadequate
stent deployment is frequently not detected by angiography.66
Fig. 1 3 shows an intravascular image of a stent within a vessel. The catheter is
seen as a small circle within the vessel lumen. The struts of the stent are
brightly echogenic and there is a gap between the struts and the vessel wall.
It is easy to appreciate that the stent is not fully deployed. Following further
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balloon dilatation, the stent is seen to be closely adherent to the vessel wall
and is now fully deployed.
Hybrid Catheters
The ability of intravascular ultrasound to monitor interventions has led to
attempts to develop so called 'hybrid' catheters. Hybrid catheters essentially
consist of a combination of an interventional catheter together with an
ultrasound catheter.67 Examples include the balloon ultrasound imaging
catheter (BUIC), atherectomy ultrasound imaging catheter and laser
ultrasound imaging catheter. 64,68,69 The BUIC has been the most successful to
date. Fig. 14 shows a diagramatic representation of a BUIC, which consists of
a balloon catheter with an ultrasound catheter through the middle. Although
the balloon material attenuates ultrasound to some degree it is not marked
and using this catheter it is possible to image the site and size of stenosis,
watch the vessel being dilated, and image the success and damage
afterwards, including the degree of luminal widening and whether there has
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Two-dimensional Image
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Figure 12.
Comparison of intravascular ultrasound with angiography. Whereas
angiography shows the stenosis, intravascular ultrasound also gives
information about plaque morphology, percent stenosis and the effects of
angioplasty on the vessel wall.
Role in Stent Placement
Case 2: Stent Deployment
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Figure 1 3.
Intravascular ultrasound of stent deployment.
The image on the left shows incomplete expansion of the stent (vessel wall
straight arrow, border of stent - curved arrow). Following further



















Balloon ultrasound imaging catheter (BUIC).
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Intravascular Ultrasound in Paediatric Interventional
Catheterisation
Coarctation
In contrast to the numerous studies in ischaemic heart disease, there are no
proper studies investigating the use of intravascular ultrasound to monitor
interventions in congenital heart disease. There have, however, been two
reports of the use of intravascular ultrasound to monitor balloon dilatation of
the aorta, describing the ability of intravascular ultrasound to accurately
measure the stenosis and detect intimal tearing and dissectionT0,7i
During the period of research for this thesis, intravascular ultrasound was
performed on 2 male patients, aged 9 and 12 years, who underwent balloon
dilatation of coarctation of the aorta. Following angiography and
measurement of pre-angioplasty gradient, the diagnostic catheter was
exchanged for a 6 French, 12.5MHz ultrasound catheter with a monorail. The
ultrasound catheter was introduced along a guide wire positioned across the
coarctation. Images of aorta distal to the coarctation site and images of the
coarctation site were recorded. Measurements of luminal diameter were
obtained both by intravascular ultrasound and angiography at the coarctation
site and site of normal aorta.
In each patient, the coarctation was dilated with a balloon catheter, sized
according to the measured diameter of the normal descending aorta.
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Following balloon dilatation, a guide wire was left across the lesion, the post-
angioplasty gradient was measured and an angiogram performed. The
ultrasound catheter was then introduced along the guide wire across the
coarctation site. Images were recorded of normal aorta and the site of
balloon angioplasty.
Figure 1 5a shows the aortogram from the 1 2 year-old male with previous
repair of coarctation. The site of recoarctation is easily appreciated. Figure
1 5b shows an intravascular image at the site of coarctation. The catheter is
seen as a small circle in the middle of the vessel lumen and the outer white ring
is the vessel wall. The Dacron patch used for repair can be seen as a brightly
echogenic area on the vessel wall. Intravascular ultrasound allows accurate
measurement of the luminal diameter at the coarctation site and comparison
with the diameter of normal aortic lumen, aiding choice of correct balloon size.
In both patients, before and after angioplasty, the measurements of lumenal
diameter at the sites of coarctation and healthy aorta by angiography and
intravascular ultrasound were within 5mm.
Following balloon dilatation the improvement in luminal diameter could be
appreciated both by angiography and intravascular ultrasound, but
intravascular ultrasound was also able to determine whether any intimal
tearing had occurred (Figs 1 6a and 1 6b).
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Figure 1 5a.
Aortogram from a 1 2 year old male with previous repair of coarctation.
There is significant narrowing due to recoarctation (arrow).
PATCH
i
Intravascular ultrasound at the site of coarctation.
The Dacron patch used for the repair is calcified and brightly echogenic.
50
Figure 1 6a.
Aortogram following balloon dilatation of coarctation.
There is marked improvement in luminal diameter.
POST BALLOON CQARCT.
Intravascular ultrasound at site of balloon dilatation of coarctation.
There is improvement in luminal diameter but no evidence of intimal tear.
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Fig 17 shows the site of coarctation folowing balloon angioplasty in the 9
year-old patient. In this patient an intimal tear has been produced, which was
not be evident on angiography. It would be interesting to know whether it is
patients who sustain such tears who are more likely to develop aneurysms in
the future. Perhaps intravascular ultrasound could help answer this question.
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Figure 17.
Intravascular ultrasound following balloon dilatation of coarctation in a 9
year old male.
There is evidence of an intimal tear (arrow).
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Pulmonary Circulation
There are no reported studies of the use of intravascular ultrasound to
monitor interventions in the pulmonary circulation. During the period of study
for this thesis, intravascular ultrasound was used to monitor a catheter
intervention of a stenosed Blalock-Taussig shunt.
Fig 1 8a shows the angiogram from a 19 year old male with tricuspid atresia,
pulmonary atresia and stenosis of a classical right sided Blalock-Taussig shunt.
On intravascular imaging narrowing at the site of stenosis was appreciated
compared with the diameter at the area of luminal patency of the shunt (Fig
18b). Following angioplasty, although there was a loss of balloon waist, there
was little improvement in luminal diameter due to the phenomenon of vessel
recoil (Fig 19a, 19b). A stent was therefore deployed, resulting in marked
improvement in pulmonary flow (Fig20a). Full stent deployment can be
confirmed by intravascular imaging (Fig20b). The stent is shown to be nicely
adherent to the vessel wall.
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Angiogram of stenosed Blalock-Taussig shunt (arrow).
Figure 18 b.
Intravascular ultrasound of Blalock-Taussig shunt.
The image on the left shows the diameter of the shunt where it is well
patent, compared with the image on the right where the shunt is stenosed
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Figure 19a.
Angiogram following balloon dilatation of stenosed Blalock-Taussig shunt.
Although there was loss of balloon waist, due to vessel recoil there is
minima! improvement in the diameter of the shunt or pulmonary blood flow.
Figure 19 b.
Intravascular ultrasound following balloon dilatation of Blalock-Taussig
shunt.
There is little improvement in luminal diameter.
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Figure 20a.
Angiogram following stent deployment in stenosed Blalock-Taussig
shunt(arrow).The shunt is well patent and there is marked improvement in
pulmonary flow.
bhhhhhhhhhhhhhhbhhhhhhi
Intravascular Image of stent.
The stent is seen to be fully deployed; the echogenic struts are nicely
adherent to the vessel wall.
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Occlusion Devices
Another potential application of intravascular ultrasound in Paediatric
interventional catheterisations which has not been explored is monitoring the
placement of occlusion devices. Fig.21 shows an intravascular image of an
arterial duct. The ultrasound catheter is seen within the aortic lumen and the
'gap' in the vessel wall is the origin of the arterial duct. Following the
deployment of one coil the duct is only partially occluded but after deployment
of a second coil the duct can be seen to be fully occluded.
Whether intravascular ultrasound could actually add any useful information to
angiography in Paediatric interventions is not certain, but its full role in
monitoring Paediatric interventions can only be determined if critical studies are
undertaken. Unfortunately studies in Paediatrics are more difficult than in the
adult population due to smaller numbers, lack of sponsorship, unwillingness to
prolong catheter procedure and screening times and difficulty in manipulating
an intravascular catheter through an often complex cardiovascular system.
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Role in Pediatric Intervention
Case 1: Closure of Patent Ductus Arteriosus Using Fibrinated
Gianturco Cods
Figure 21.
Intravascular image of duct occlusion by Gianturco coils
In the image on the far left, the ultrasound catheter is seen within the lumen
of the aorta. The'gap' in the wall of the aorta is the origin of the arterial
duct.
In the middle image, the duct can be seen to be partly, but not completely,
occluded by one coil.
In the image on the right, following deployment of a second coil the duct can
be seen to be completely occluded.
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3. Intravascular imaging of the pulmonary arteries
Intravascular ultrasound of the pulmonary arteries has not received much
interest, probably because a useful application is not so immediately apparent
and because commercial promotion of the technique for use in pulmonary
vessels is not so financially lucrative as studying atherosclerosis. There are,
however, three potential areas of application:
1. Diagnosis of pulmonary thromboembolism
In patients in whom a diagnosis of pulmonary thromboembolism remains
unclear despite angiography, intravascular imaging may allow direct
visualisation of thrombus, confirming the diagnosis (Fig. 22). There are a few
case reports describing this application of intravascular ultrasound, but it is
unlikely to be a major clinical use for the technique.72,73
2. Evaluation of therapeutic catheterisation
As described above, in subjects undergoing therapeutic catheterisation for
dilatation of stenosed pulmonary vessels, intravascular ultrasound may help
evaluate results, such as showing intimal tears or dissection secondary to
angioplasty, or confirming adequate deployment of stents.
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Figure 22.
Intravascular ultrasound within a pulmonary artery in a 9 year old male with
pulmonary hypertension secondary to multiple thromboemboli from a
ventriculoperitoneal shunt.
The catheter is seen within the vessel lumen. The echogenic homogenous
material is thrombus(arrow).
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3. Assessment of pulmonary hypertension
The third potential use of pulmonary intravascular ultrasound is in the
investigation of pulmonary hypertension and pulmonary vascular disease.
Initial studies of pulmonary intravascular imaging in patients with pulmonary
hypertension have shown evidence of medial and intimal thickening, as well as
atherosclerotic lesions very similar to those seen in coronary artery
disease J4.75 Such findings suggest that intravascular ultrasound may be of use
in evaluating the morphological changes which occur in pulmonary hypertension
and this potential application of intravascular ultrasound will be explored
further in this thesis(Chapter 3).
4. Endothelial Function and Vascular Reactivity
Intravascular ultrasound gives excellent imaging of vessel luminal dimensions
and therefore provides a method of studying vascular reactivity in life. There
are surprisingly few studies involving this application of the technique and most
of the studies have used intravascular Doppler to assess vascular flow rather
than 2-D imaging to observe changes in luminal dimensions.76 The use of
intravascular ultrasound for the study of pulmonary vascular reactivity will be






The initial studies of intravascular imaging in pulmonary hypertension have
suggested that intravascular ultrasound can detect medial and intimal
thickening as well as changes of atherosclerosis in the pulmonary arteries in
pulmonary hypertension.74,75 This raises the possibility that the technique may
provide a method of evaluating pulmonary vascular morphology in life at the
time of cardiac catherisation or surgery without the need for lung biopsy.
Naturally using intravascular ultrasound to assess morphology in pulmonary
hypertension could only be of clinical use if the changes in vessels accessible to
the ultrasound catheters reflected the severity of pulmonary vascular disease.
The relation between morphological changes in the proximal and peripheral
vessels will therefore be explored later in this thesis(Chapter 6).
Aims
The purpose of this study was to evaluate the potential of intravascular
ultrasound as a method of studying vascular morphology in life in pulmonary
hypertension with reference to the following:
1. Safety and ease of use of the technique in studying patients with pulmonary
hypertension.
63
2. Identification of technical and other problems.
3. Description and quantification of morphological changes evident on
intravascular imaging of pulmonary hypertensive arteries.
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METHODS
Approval for the study was granted by the Hospital Ethics Committee.
Patients with endstage pulmonary vascular disease were chosen for study as
pathophysiological changes were likely to be most evident in this population. In
addition, the feasibilty of pulmonary intravascular imaging in infants with left to
right shunts was evaluated as it is this group most likely to have modifiable
disease.
Patients
Intravascular ultrasound was performed in 10 young adults (age 20-35 years)
with endstage pulmonary vascular disease secondary to a left to right shunt
and 4 infants (age 3-6 months) with a left to right shunt and reversible
pulmonary hypertension.
Table C shows the clinical characteristics of the patients, including the
pulmonary and systemic pressures in the four infants. Pulmonary arterial
pressure was greater than twice systemic in three of the infants and less than
one third systemic in one infant.
In the young adults intravascular ultrasound studies were done at the time of
cardiac catheterisation which was being performed as part of an assessment
for cardiopulmonary transplant. On the day prior to cardiac catheterisation,
the procedure and potential risks of intravascular ultrasound were explained
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Table C. Clinical characteristics of patients.
Patient Age Diagnosis PAP SAP PVR
*GR 26 VSD, Eisenmenger's 110/60 120/65 12
*DT 34 VSD, Eisenmenger's 105/65 115/65 15
*NA 31 PDA, Eisenmenger's 95/60 110/60 12
*DB 22 VSD, Eisenmenger's 95/60 115/65 17
*SL 35 VSD, Eisenmenger's 90/60 110/65 15
KC 24 AVSD, Eisenmenger's 110/60 120/70 12
AT 32 WS, Eisenmenger's 110/65 110/60 12
DMB 28 VSD, TGA, Mustard's 110/60 105/65 12
JW 19 PDA, Eisenmenger's 110/55 105/60 8
SW 22 PDA, Eisenmenger's 110/65 110/65 9
DM 3 months ASD 25/15 70/40 -
AS 4 months AVSD 45/15 60/30 -
JH 5 months VSD 45/17 70/35 -
CM 3 months AVSD 30/15 65/40 _
PAP; pulmonary arterial pressure(mmHg), SAP; systemic arterial
pressure(mmHg), PVR; pulmonary vascular resistance(Wood Units/m2).VSD;
ventricular septal defect, PDA; patent arterial duct, AVSD; atrioventricular septal
defect, WS; Waterston shunt, TGA; transposition of the great arteries.
*
= Patients in whom vasodilator studies performed.
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and each patient given an information sheet to read. Informed consent for the
intravascular imaging was obtained prior to commencing cardiac
catheterisation.
In the infants, the studies were performed at the time of cardiac surgery since
cardiac catheterisation is now rarely performed in very young infants with left
to right shunts in our institution. The procedure and potential risks of
intravascular ultrasound were explained to the parent/guardian and informed
consent for the intravascular studies obtained from the parents prior to
commencing surgery.
Intravascular Ultrasound
6F, 20MHz, mechanically rotated intravascular ultrasound tipped catheters
(Mansfield Scientific) were used for the studies in the young adults and 3.5F,
30MFIz mechanically rotated ultrasound catheters (Mansfield Scientific)
employed for the studies in the infants. The axial resolution of the catheters
was 0.1 mm and lateral resolution of the order of 0.2-0.3mm depending on the
gain setting. Images were displayed on a Sonos 100 (Flewlett Packard) or
Diasonics ultrasound machine adapted for use with intravascular catheters.
Prior to in-vivo use the function and calibration of each ultrasound catheter
was tested in-vitro by inserting the catheter in a sterilised thin glass cylinder
filled with water. The area as determined by ultrasound was validated against
the measured diameter of the cylinder.
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Intravascular Imaging in Patients with Eisenmenger's
In the patients with Eisenmenger's cardiac catheterisation was performed with
the patient sedated (Diazepam 10mg orally 1 hour prior to procedure) and
breathing room air. The right groin was infiltrated with Lignocaine 2% and the
right femoral vein cannulated with a 7 French sheath with a haemostatic valve
(Cordis) using the Seldinger technique.
Following routine right heart catheterisation during which measurement of
pulmonary arterial pressure and calculation of pulmonary vascular resistance
were obtained, the 7 French sheath was exchanged over a guide wire for an 8
French biopsy sheath (Cordis). The biopsy sheath was introduced into the
pulmonary artery. The intravascular ultrasound catheter was then advanced
into the pulmonary arteries through the biopsy sheath until almost wedged,
avoiding contact between the probe and the vessel wall which would result in
'ring-down artifact'. Once the ultrasound probe was in a satisfactory and
stable position, images were recorded. The procedure was repeated for more
than one segment of lung. On completion of imaging of the pulmonary arteries,
the ultrasound catheter and biopsy sheath were withdrawn through the right
heart and inferior vena cava while still imaging. The sheath and ultrasound
catheter were then removed and haemostasis obtained with simple local
pressure.
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Intravascular Imaging in Infants
The infants were anaesthetised for cardiac surgery. Following thoracotomy
and prior to the infant going on cardiopulmonary bypass, the main pulmonary
artery was cannulated with an 1 8 Gauge Vygon needle and exchanged over a
wire for a 5F sheath (Cordis). A purse string suture was placed around the
sheath. The mean pulmonary arterial and systemic pressures were recorded.
The intravascular ultrasound probe was then advanced through the sheath
and into the pulmonary tree until almost wedged. Images were recorded once
the probe was in a stable position. Images were recorded on withdrawal of
the catheter from branch pulmonary arteries to pulmonary trunk. All images
were recorded on VFIS video tapes. At the end of the procedure the catheter
and sheath were removed and haemostasis was achieved by pulling tight the
purse string suture.
Analysis of Results
Images were analysed at a later date using a Image-Vue Work Station to
enable measurements to be made on the recorded video images. Images were
analysed for the following:
1. The presence or absence of the characteristic trilayer appearance of the
vessel wall.
2. The ability to distinguish and measure the media.
3. The presence of intimal thickening including atherosclerotic lesions.
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RESULTS
Intravascular imaging in Patients with Eisenmenger's
Complications
There were no adverse effects due to intravascular imaging experienced by
any of the patients. In two patients with Eisenmenger's the technique had to
be abandoned; one due to failure to enter the pulmonary arteries with the
intravascular ultrasound catheter (DMB) and the other due to the sharp angle
of the branching of the pulmonary arteries causing 'binding' of the ultrasound
catheter with loss of imaging (JW). Complete transducer failure occurred
during imaging in four patients with Eisenmenger's and in one infant, requiring
replacement with a new ultrasound catheter. It was unclear why the
transducers failed, but probably simply reflected catheter fragility. A total of
21 catheters were used for 14 patients at a cost of £11,000.
Morphology
In the patients with Eisenmenger's it was possible to enter the third and fourth
order branch pulmonary arteries. The catheter could be advanced until wedged
but this resulted in marked 'ring down' artifact with merging of echo signals
which completely obscured the layers of the vessel wall. To produce a
satisfactory image the catheter had to be withdrawn until there was a
distance of approximately 1 mm between the external surface of the catheter
and the vessel wall. This meant that the smallest vessels which could be
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imaged were of the order of 4-5mm in diameter. An average of three lung
segments was analysed for each of the patients.
A problem with imaging was that the echogenic density of the vessel wall
tended to vary with vessel wall motion. As the vessel became more distended,
areas of 'drop-out' would occur resulting in the illusion of gaps in the vessel
wall.
In the patients with Eisenmenger's, none of the vessels imaged had the
characteristic trilayer appearance normally described with intravascular
imaging. Instead, the vessel wall consisted of a single echogenic layer (Fig
23,24) and it was not possible to sufficiently define the boundaries of the
media in order to obtain measurements of medial thickness.
In all the patients with Eisenmenger's the luminal surface of the
intraparenchymal pulmonary arteries was found to be irregularly thickened
suggesting intimal hypertrophy. Atherosclerotic lesions similar to those
described in systemic vessels were identified in all but one patient.
As the catheter was withdrawn from branch pulmonary arteries into right
ventricle the main pulmonary arteries and pulmonary trunk were imaged.
Despite using a biopsy sheath it was impossible to stabilise the catheter
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Figure 23.
Intravascular Image within the pulmonary artery of a 26 year-old male with
a VSD and Eisenmenger's Complex.
The ultrasound catheter is seen as a small circle in the vessel lumen. The
outer white ring is the vessel wall. The vessel wall (v) is seen as a single
layer and it is not possible to define the media with certainty. The intima is
thickened and irregular and there is atheromatous plaque (arrow) similar to
that seen in peripheral vessels.
Figure 24.
Intravascular Image within the pulmonary artery of a 19 year-old male with
a VSD and Eisenmenger's Complex.
The ultrasound catheter is seen as a small circle in the vessel lumen. The
outer white ring is the vessel wall(v). The vessel wall (v) is seen as a single
layer. The intima is thickened and irregular and there is atheroma (arrow).
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centrally in the larger vessels. The catheter moved to and fro with each heart
beat causing the imaged vessels to appear elipsoid. The main pulmonary
arteries appeared as a single echodense layer typical of elastic arteries (Fig.
25).
As the transducer crossed the pulmonary valve the valve cusps were seen as
thin mobile echogenic structures (Fig.26). The muscle of the right ventricular
outflow tract was visualised but the whole ventricle could not be visualised in
one image due to the high frequency of the transducer reducing available field
of view.
Intravascular Imaging in Infants
Complications
One of the infants developed ventricular tachycardia when the ultrasound
catheter was introduced into the right ventricular outflow tract. The
arrhythmia resolved on immediate removal of the catheter. There were no
problems of bleeding from the site of pulmonary arterial puncture in any of the
patients. Postoperative course was uncomplicated in three of the infants but
the fourth, DB, who had systemic pulmonary pressures at the time of surgery,
suffered pulmonary hypertensive crises postoperatively and required 48 hours
of prostacyclin. Subsequently his recovery was unremarkable. All four infants
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Intravascular ultrasound within the pulmonary trunk.
Figure 26.
Intravascular image of a pulmonary valve.
The valve leaflets are seen as thin echogenic lines on either side of the
catheter.
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Intravascular Imaging in Infants
As the ultrasound catheters were advanced into the pulmonary arterial tree
without fluoroscopic screening, it was impossible to be certain about the exact
position of the catheter. Direct palpation of the right and left pulmonary
artery allowed determination of which lung was being catheterised. In all four
infants the ultrasound catheter entered the left but not the right lung vessels,
presumably due to the angle at which the sheath was positioned in the main
pulmonary artery and the angle of origin of the left pulmonary artery. Without
fluoroscopic screening it was deemed unsafe to use a guidewire or long sheath
and this made it difficult to manouevre the catheter. Only in two infants was it
possible to advance the catheter to a wedged position. In the other two it
was impossible to advance the catheter farther than the left main pulmonary
artery.
Morphology
In the infants the smallest vessels imaged were approximately 4-5mm; i.e
relatively large elastic pulmonary arteries. The vessel wall appeared as a single
echodense layer and it was not possible to accurately differentiate the three
morphological components of the vessel wall. The intimal surface was thin and




Intravascular ultrasound of a pulmonary artery in a 4 month old infant with
a ventricular septal defect and pulmonary hypertension. The vessel wall is
indicated by the arrow.
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DISCUSSION
Technical considerations in intravascular imaging
Transducers - mechanical versus phased array
Intravascular imaging is performed using a cardiac catheter with an ultrasound
transducer built into the tip. For the ultrasound transducer itself there are
two possible approaches. One is to use a mechanically rotated transducer or
rotating mirror and the other is to use an electronic array. Both approaches
have limitations which must be taken into account when interpreting images.
Mechanical transducers are difficult to make within consistent mechanical
specifications. As a result, the transducer rotation speed may vary due to
mechanical drag, producing distortion of the image and affecting accuracy of
quantitative measurements.77 This is especially a problem when the drive
shaft is bent by a tortuous vessel.
The main advantage of the multi element array system is that it overcomes
the problem of non-uniform rotation. In addition, as there is no mechanical
drive shaft required, the catheter is more flexible and able to negotiate
tortuous vessels. The disadvantage of the multi-element system is that it
requires complex hardware and software for image reconstruction which
makes the transducers expensive.7» The choice of mechanical as opposed to
phased array transducers in this study was mainly influenced by commercial




A major problem encountered when imaging small vessels with intravascular
ultrasound is 'ring-down' artifact. This occurs secondary to high amplitude
oscillations of the transducer piezoelectric material and results in a heaping up
of echoes from structures located close to the transducer. The result is a
bright echogenic image with loss of definition. The effect can be reduced in
mechanical catheters by using a rotating acoustic mirror to produce a greater
signal path length from transducer to vessel lumen. An acoustic mirror is not
suitable for electronic array catheters as the transducer elements are surface
mounted. Ring-down is eliminated in electronic array catheters by the process
of digital subtraction. A reference image containing ring-down artifact is
obtained while imaging a large vessel such as the aorta and thereafter the
central portion of this image is subtracted from all subsequent frames.
Variations in acoustic reflectance
One of the problems frequently encountered in intravascular imaging is low
acoustic reflectance from normal intima which results in echo 'drop-out' and
gives the appearance of gaps in the vessel wall. Conversely, atherosclerotic
or calcified intima is intensly echoreflective and may obscure imaging of
underlying structures. Such problems were encountered in the patients with
Eisenmenger's syndrome in whom the intima was thickened and atheroclerotic
lesions common. As 'drop-out' makes accurate measurement of luminal area
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difficult it is important to measure luminal area where the luminal circumference
appears complete on imaging.
Manipulation of the Catheter
Catheter 'Binding'
In patients with complex congenital heart defects, manipulation of the soft
floppy intravascular imaging catheters around sharp angles or across
abnormal valves may be difficult. Such difficulties were experienced in one of
the patients with Eisenmeneger's in whom it was impossible to enter the
pulmonary arteries. A problem peculiar to the mechanical catheters is that the
catheter drive shaft is situated within the body of the catheter and will 'bind' if
required to negotiate too sharp an angle. Naturally, this results in loss of
imaging as happened in one of the patients with Eisenmenger's.
Catheter Guidance
There are two methods employed to improve catheter guidance. One is to use
a guide wire and many commercial catheters now have a guide wire monorail.
An alternative method is to use a long sheath, such a myocardial biopsy
sheath which can be introduced into the pulmonary arteries. It was found that
for pulmonary arterial studies, superior catheter guidance and stability were
obtained using a sheath. Catheter stability is of supreme importance to
ensure that the catheter remains well centred within the lumen as the vessel
lumen tends to appear ellipsoid when the catheter is not centralised, affecting
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the accuracy of measurements of luminal area. In addition, as described
above, 'ring-down' artifact occurs when the catheter is too close to the vessel
wall.
Complications
Only one patient experienced complications related to intravascular imaging
and in this patient the arrhythmia induced by the ultrasound catheter resolved
on removal of the catheter. Intravascular ultrasound appeared to add no
significant morbidity to either cardiac catheterisation or surgery.
Morphology of pulmonary arteries on intravascular imaging
In the patients with Eisenmenger's, the boundaries of the three mural layers of
the pulmonary arteries studied could not be truly defined despite the claims
from previous studies that medial thickening is demonstrable on intravascular
imaging of pulmonary hypertensive vessels.74-75 Instead, the wall of the
pulmonary arteries studied was found to have a single echodense layer. This is
not surprising as pulmonary arteries accessible to intravascular imaging are
elastic arteries and therefore the media has more echodense elastin giving the
vessel wall the appearance of a single echodense layer. Although, the muscular
pulmonary arteries would be more likely to have a trilayer appearance, these
vessels are too small to allow imaging by current intravascular ultrasound
catheters.
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Confirming the findings of others, the intimal layer was found to be irregular
and thickened, and atherosclerotic lesions, similar to those found in systemic
vessels were demonstrated in the patients with Eisenmenger's.74,75 As
previously mentioned, atherosclerotic lesions are found in postmortem lungs
from patients with pulmonary hypertension as young as three years old.79
Atherosclerotic plaques are also demonstrable in normal elderly individuals as
part of ageing.7 it is quite feasible that atherosclerotic lesions within a
hypertensive pulmonary ciculation could behave as those in the systemic
circulation with plaque rupture and formation of thrombi. Such thromotic
episodes could then contribute to pulmonary hypertension and the progression
of pulmonary vascular disease.
Intravascular Morphology in Infants with Pulmonary Hypertension
In the infants it was possible only to image relatively large vessels of around 4-
5mm in diameter i.e 2nd order branch pulmonary arteries. As in the patients
with Eisenmenger's it was not possible to distinguish a trilayer appearance on
intravascular imaging. Unlike the older patients with Eisenmengers the intima in
the infants was a barely visible thin layer as would be expected on imaging
healthy intima.
In both groups of patients, in the intraparenchymal arteries, the vessel wall
appeared to be surrounded by an echogenic ring. These outer echogenic rings




Obviously a major limitation when studying pulmonary vascular morphology
with intravascular ultrasound is that the smallest pulmonary vessels accessible
to current imaging catheters are relatively large elastic pulmonary arteries
(especially in infants), whereas pulmonary vascular disease is a disease largely
affecting peripheral vessels. When imaging elastic arteries it is often not
possible to define three vessel layers probably due to the echogeneity of the
elastin rich media. In addition the echoreflectivity of a thickened intima may
obscure underlying mural structure.
The pathological findings which could be demonstrated in the patients with
Eisenmenger's were those of intimal thickening and atherosclerotic lesions and
the suggestion of an overall increase in vessel wall size. Therefore, although
such lesions may be found in the elderly as part of the normal aging process,
the finding of pulmonary atheroma in a young patient is likely to indicate long¬
standing severe pulmonary hypertension.
In infants the boundaries of each vessel wall layer were not clear enough on
intravascular imaging to allow meaningful measurements to be made. It could
be argued, however, that if the intima and adventitia are thin walled as in
normal vessels, measurement of the vessel wall itself would be representative
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of medial thickness. Measurements of medial thickening in the elastic
pulmonary arteries of patients with potentially reversible pulmonary
hypertension would only be of use, however, if they reflected severity of
pulmonary vascular disease. This will be explored later in this thesis.
In conclusion, intravascular ultrasound is able to detect changes of intimal
thickening, atherosclerosis and vessel wall thickening in the elastic pulmonary
arteries in patients with advanced pulmonary hypertensive disease. In infants,
intravascular ultrasound allows measurement of vessel wall thickness which is
likely to reflect medial thickness. If the degree of medial thickness in the elastic
pulmonary arteries proved to reflect severity of pulmonary vascular disease
and was of a magnitude to be detectable by intravascular imaging, the
technique potentially could be used to assess pulmonary vascular morphology






As early as 1962, Dawes demonstrated that the high pulmonary vascular
resistance in lamb foetal lung was mainly secondary to vasoconstriction rather
than due to mechanical factors.so He also demonstrated that vascular
resistance could be lowered by raising arterial p02 or giving injections of the
vasodilator Acetylcholine.
In 1 980 Furchgott and Zawadzki showed that healthy endothelium produced a
relaxing factor which was important for the control of vasomotor tone.si This
factor has now been identified as endothelial derived relaxing factor which has
the same molecular structure as Nitric Oxide. Vasodilators are now often
classified as endothelial-dependent and endothelial-independent. Endothelial-
dependent factors exert their effect by inducing release of relaxing factors
from the endothelium whereas endothelial-independent factors act direcly on
the endothelium to cause vasodilation. An example of an endothelial dependent
factor is Acetylcholine. Endothelial-independent factors include Prostacyclin,
Nitric oxide and Adenosine.
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Pulmonary vasoconstrictors
More recent studies have demonstrated that there may also be a constricting
substance (or sustances) secreted by the endothelium under certain
conditions, including hypoxia. This substance has been called Endothelin.82 it
has been postulated that Endothelin might have a role in the development of
pulmonary vascular disease. A recent study by Haworth et al, however,
showed that Endothelin does not appear to be elevated in the pulmonary blood
of patients with pulmonary hypertension and its precise role in the development
of pumonary vascular disease remains unclear.83
Persistent foetal circulation
There is much that remains unknown about the reactivity of lung vessels, but it
appears that some individuals are particularly sensitive to factors causing
vasoconstriction. For example, in some newborns, pulmonary vascular
resistance fails to drop following delivery. This results in poor pulmonary blood
flow, the arterial duct remains patent, there is a right to left shunt at ductal
and atrial level, and the neonate becomes cyanosed and acidotic. The condition
is known as persistent foetal circulation.84 Many infants who develop
persistent foetal circulation have a history of birth asphyxia or difficult delivery
but many others have no apparent precipitating factor. The mechanism for the
condition is unknown and mortality is high despite administration of
vasodilators and ventilation.
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Pulmonary reactivity in left to right shunts
In infants with a left to right shunt, it is unclear why, given a similar defect and
shunt size, some appear to have a particular prediliction to developing
pulmonary vascular disease. Patients with Down's syndrome appear
particularly at risk.85 Following surgery for left to right shunts a percentage of
individuals develop pulmonary hypertensive crises during which there are
sudden acute rises in pulmonary vascular resistance resulting in reduced
pulmonary blood flow and hypoxia.86 Again, the mechanism of pulmonary
hypertensive crises is not clear, nor is it clear why certain individuals have such
labile vascular reactivity.
Pulmonary reactivity at high altitudes
Individual differences in pulmonary vascular reactivity are also manifest at high
altitudes. The reduction in inspired p02 at high altitudes results in relative
hypoxia which causes pulmonary vascular constriction. Subjects who live at
altitudes greater than 30,000 feet have a higher mean pulmonary arterial
pressure; approximately 25mmHg compared with 17mmHg at sea level. On
ascending from sea level to high altitudes, pulmonary vascular resistance rises,
but there are some individuals who appear to have particularly reactive vessels
and develop pulmonary oedema. The only treatment is rapid descent but




There is growing interest in the role of endothelial dysfunction and vascular
reactivity in the development of cardiovascular diseases with a need to
develop methods to study endothelial function in life. The evaluation of
pulmonary vasodilators in-vivo has largely consisted of measuring changes in
pulmonary vascular resistance following administration of vasodilators. More
recently Celermajer et al used a combination of arteriography and Doppler
flow to evaluate both local and peripheral vessel dilatation in response to
vasodilators.88
Intravascular ultrasound to assess vascular reactivity
Intravascular ultrasound produces clear images of the lumen. In-vivo and in-
vitro studies have shown that intravascular ultrasound gives accurate
measurements of luminal size and is superior to angiography in this respect,
particularly where intimal disease is present.48-so in addition, measurement of
luminal area by intravascular ultrasound appears to be very reproducible (as
demonstrated by studies of inter- and intra-observer variation) and changes in
luminal diameter can be measured continuously during infusion of vasodilators,
allowing immediate detection of any change.89,90 Although intravascular
ultrasound would appear to be an ideal method of measuring luminal diameter
the technique has rarely been used in studies of vascular reactivity.9T92,93
87
Aims
The aims of this study are as follows:
1. To assess the effects of pulmonary vasodilators on local and distal
pulmonary vessels in pulmonary hypertension using intravascular ultrasound to
measure changes in local luminal dimensions.
2. To determine whether intravascular ultrasound is a useful and safe technique
for the evaluation of pulmonary vascular reactivity.
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MATERIALS AND METHODS
Approval for the vasodilator studies was granted by the Hospital Ethics
Committee. Prior to cardiac catheterisation the nature, anticipated duration
and potential side-effects of the studies were explained to the patients. Three
patients refused to consent for vasodilator studies due to the anticipated
length of the studies. In two patients it was not possible to image the
pulmonary arteries for reasons described in Ch3, p64, therefore vasodilator
studies were performed in only five of the young adults with Eisenmenger's
syndrome.
Vasodilator studies were not performed in the infants as the effects of
ventilation, oxygen and anaesthetic agents would have confounded
interpretation. In addition it was felt by the surgeon that the anticipated
length of the studies would have posed an unacceptable delay to proceeding
with surgery.
Technique
Following completion of routine cardiac catheterisation, the cardiac catheter
was exchanged for an 8F biopsy sheath which was advanced into the
pulmonary artery as described in Ch3, p63.
A 22 gauge arterial catheter was inserted into the right femoral artery to
allow simultaneous measurement of systemic arterial pressure and arterial
89
blood gas sampling. A second venipuncture was made in the right femoral
vein and, using the Seldinger technique, a 6F sheath was introduced into the
vein and a 6F multipurpose cardiac catheter (Cordis) was advanced through
the sheath until positioned in the main pulmonary artery. The multipurpose
catheter was used to sample blood for oxygen saturations and to measure
pulmonary arterial pressures.
The intravascular ultrasound catheter was introduced through the cardiac
biopsy sheath and into the pulmonary arteries until almost wedged. Once the
ultrasound catheter was stabilised in a position where clear images of the
lumen were obtained, the vasodilator studies were commenced. The choice of
vasodilators for this study was largely influenced by availability. The equipment
required for the administration of Nitric Oxide was not available and there
were no facilities for measuring Acetylcholine levels. Oxygen, Prostacyclin and
Adenosine were therefore chosen as pulmonary vasodilators. Oxygen was
delivered by mask. Saline, Prostacyclin and Adenosine were infused through the
side-arm of the biopsy sheath directly into the pulmonary vessel imaged.
Administration of vasodilators
The vasodilators were administered as follows:
Oxygen
100% oxygen was delivered by mask for 10 minutes.
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Saline
A bolus of 50ml of Saline was infused directly into the pulmonary artery to
investigate the effects of volume alone.
Adenosine
Adenosine was infused into the pulmonary arteries, at an initial rate of
50ug/kg/min and increased by 50ug/kg/min every two minutes until either a
maximum dose of 500ug/kg/min, or the development of side effects, including
a reduction in mean systemic blood pressure by 30%, chest pain, dyspnoea,
tingling, parasthaesea or nausea.94
Prostacyclin
Prostacyclin was infused directly into the pulmonary arteries, at an initial rate
of 5ng/kg/min and increased by 5ng/kg/min every 5mins until either a
maximum of 25ng/kg/min or the development of side effects including a
reduction in mean systemic blood pressure by 30%, headache, nausea or
flushing.
An interval of 10 minutes was allowed between each vasodilator to allow
haemodynamics to return to baseline.




Pulmonary vascular resistance was calculated at the beginning of the
administration of each vasodilator, following each increment in dose, and at
the end-point of each study. Blood for oxygen saturations was taken from the
pulmonary artery, superior and inferior vena cavae and femoral artery.
Oxygen saturations were measured using a standard blood gas analyser.
Oxygen consumption was measured simultaneously using a respiratory gas
analyser (MC Horizon, Sensor Medics Ltd.) and cardiac outputs calculated
from the equations:-
Systemic blood flow =
Systemic oxygen uptake
Systemic arterial oxygen content - Systemic venous oxygen content
Pulmonary blood flow =
Pulmonary oxygen uptake
Pulmonary venous oxygen content - pulmonary arterial oxygen content
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Pulmonary vascular resistance was then calculated from the following
equation:-
Pulmonary vascular resistance =
Pulmonary arterial pressure - left atrial pressure
Pulmonary blood flow
where, Pulmonary blood flow =
Pulmonary oxygen uptake
Pulmonary venous oxygen content - pulmonary arterial oxygen content
Measurements of luminal area
Images of luminal area were recorded at the beginning of each vasodilator
study, following each increment in dose, and at the end-point of each study.
Images were recorded on Super VHS video tapes for a minimum of 20 cardiac
cycles.
Recorded images were analysed later using an Image-Vue work station.





Three patients experienced Adenosine related side-effects of chest pain and
bradycardia but symptoms resolved within seconds of ceasing the infusion.
There were no other complications experienced by any of the patients.
Vasodilator studies
Fig.28 shows the response of luminal area to administration of Oxygen,
Prostacyclin, Saline and Adenosine. There was no significant change in luminal
area or pulmonary vascular resistance in response to the administration of
any of the agents in the group as a whole (p>0.05, Mann-Whitney U). A
notable local vasodilator response to Prostacyclin and Adenosine was,
however, observed in one of the patients (GR). The response to Adenosine
was particularly marked but at a dose which also resulted in side effects(Fig
29). Side effects resolved within seconds of ceasing the Adenosine infusion.
The local vasodilator response to adenosine was reproducible, but as the
response was transient, there was not sufficient time to obtain samples to
calculate any change in pulmonary vascular resistance. In the same patient,
however, the calculated pulmonary vascular resistance fell from 1 2 Wood
Units/m2 to 9 Wood Units/m2 in response to Prostacyclin.
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Figure 29.
Intravascular ultrasound showing dramatic response of pulmonary artery




In the three patients who developed Adenosine related side effects,
bradycardia was associated with marked local pulmonary vasoconstriction
visible by ultrasound. This effect resolved with improvement of heart rate
within seconds of ceasing the adenosine infusion.
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DISCUSSION
The purpose of this study was to evaluate the potential of intravascular
ultrasound as a method of studying vascular structure and reactivity in life in
patients with pulmonary hypertension. As discussed previously, a major
drawback in using intravascular ultrasound is that the smallest pulmonary
vessels accessible to current imaging catheters are elastic pulmonary arteries,
wheareas pulmonary vascular disease is essentially a disease of peripheral
vessels. Nevertheless, in-vitro studies of pulmonary arterial reactivity are
usually performed on strips of elastic pulmonary artery, therefore it is not
unreasonable to consider elastic pulmonary arteries as a model for changes in
more peripheral vessels.
Evaluation of pulmonary vasodilators in-vivo mainly has consisted of assessing
changes in pulmonary vascular resistance. More recently Celermajer et al used
a combination of angiography and Doppler flow studies to measure both local
and peripheral vessel dilatation in response to vasodilators.88 The problem with
angiography is that a single image may not be at the point of maximal vessel
dilatation. Intravascular ultrasound, however, enables continuous and accurate
measurement of luminal dimensions, allowing immediate detection of any
change and measurement of maximal luminal area. Furthermore, the technique
requires no contrast which may be hazardous in patients with pulmonary
hypertension.
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In keeping with the severe advanced pulmonary vascular disease in
Eisenmenger's Syndrome, pulmonary vasodilators produced no significant
response in the patient group as a whole. In view of the advanced disease in
this population they were perhaps not the best group in which to study
vascular reactivity, but for reasons discussed above, we were unable to study
vascular reactivity in the infants who would have had more labile pulmonary
haemodynamics. Nevertheless, Prostacyclin and Adenosine resulted in a notable
increase in vessel luminal area in one patient with Eisenmenger's(GR). Although
we were also able to detect a slight reduction in peripheral vascular resistance
to Prostacyclin in the same patient (GR), our method of measuring pulmonary
vascular resistance did not allow simultaneous detection of changes in
peripheral vessels in response to Adenosine as the effects were too transient.
The use of intravascular Doppler, as described by Calermajer et al, would have
helped to overcome this problem by allowing continuous measurement of blood
flow velocity and estimation of change in peripheral vascular resistance during
infusion of Adenosine.88
It is not clear why the patient GR responded so markedly to Adenosine. The
potency of Adenosine as a pulmonary vasodilator is well recognised and other
researchers have found the drug to cause pulmonary vasodilation where other
agents have failed.94,95 The precise mechanism of action is not clear but it is
believed to act on the A1 and A2 receptors on the endothelium to increase
cyclic AMP.96 A longer acting analogue with a better therapeutic ratio would be
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required for its use in clinical practice but clearly the pulmonary vasodilator
effects of this agent merit further investigation.
Adenosine induced bradycardia resulted in vasoconstriction visible by
ultrasound. Although it has been believed that pulmonary hypertensive crises
result from reactive constriction in the peripheral vessels it is possible that
more proximal vessels also are involved. Vasoconstrictors such as Endothelin
may play an important role in the development of pulmonary vascular
disease^ and intravascular ultrasound could provide a valuable technique for
studying such vasoconstrictors in life.
Although intravascular ultrasound gives excellent definition of the vessel lumen,
in the presence of luminal disease, such as occurs in atherosclerosis and
hypertension, it may become more difficult to decide what to define as 'lumen',
increasing inter and intraobserver variability. In addition, the smaller the
vessel studied the more significant becomes observer error and therefore the
use of intravascular ultrasound for determining the local effects of
vasodilators is likely to be most accurate for measuring changes in larger
vessels. Recently there has been increased interest in the role of the larger so-
called 'capacitance' vessels in the development of cardiovascular diseases. In
an article in the British Heart Journal entitled 'Large arteries are more than
passive conduits', the authors, Ramsay and Jones suggested that for too long
the large vessels have been forgotten and that diseases of these vessels result
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in alterations of distensibility and pulsatility which can have a profound effect
on the cardiovascular system.97 Endothelial dysfunction of the larger vesels
may contribute to reduction of arterial distensibility in hypercholesterolaemia98
and hypertension.99 Some medications known to be benefical in treating
cardiovascular diseases, including ACE inhibitors, not only cause vasodilation of
small vessels but also reduce vessel wall stiffness in larger vessels. 100
Intravascular imaging could provide an ideal technique for assessing the effects
of vasodilators in these vessels.
In conclusion, intravascular ultrasound is a technique which may be used in the
study of pulmonary hypertension in life either at the time of catheterisation or
at the time of surgery, adding little morbidity to either procedure. The
technique gives excellent definition of the vessel lumen, allowing measurement of
vessel luminal area and assessment of local vascular reactivity to vasodilators
and vasoconstrictors. Intravascular imaging thus provides a unique method of
assessing vascular reactivity in life, not only in the pulmonary circulation but






in 1944 Rabi won the Nobel Prize for the discovery of nuclear magnetic
resonance. He observed that hydrogen atoms in a magnetic field could absorb
radiofrequency electromagnetic energy at a sharply defined or "resonant"
frequency.102 The first clinical applications of nuclear magnetic imaging came in
the 1970's due to the efforts of Damadian and Lauterbur who produced the
first human images and used the technique for the detection of
malignancy.103,i04 Since then magnetic resonance imaging has been used to
study diseases of the brain, spinal cord, musculoskeletal system, abdomen and
pelvis.102 More recently magnetic resonance imaging has been applied to the
cardiovascular system.
Cardiac Magnetic resonance imaging(MRI)
There are a number of features which make magnetic resonance imaging idea!
for the clinical evaluation of cardiovascular diseases. The technique has a wide
field of view, is able to image blood vessels with excellent spatial and temporal
resolution and does not require intravascular contrast material or ionizing
radiation. 102,i05 Despite these attractions the technique has had a relatively
minor role in cardiovascular medicine. This is largely because the information
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obtained by echocardiography often obviates the need for magnetic resonance
imaging. In addition, magnetic resonance imaging is expensive and not always
readily available. Motion artifact and previously lengthy scanning times have
also contributed to its slow clinical use. Recently, however, there have been a
number of technological developments which have reduced scanning time and
led to increasing application for magnetic resonance imaging in cardiovascular
medicine.102
Cardiac applications of Magnetic resonance imaging
The development of rapid imaging techniques has now made it possible to
define cardiac anatomy and connections, evaluate ventricular dimensions and
function, and calculate blood flow velocities and shunts using magnetic
resonance imaging. 105,106,107 |n congenital heart disease, magnetic resonance
imaging has proved particularly useful in defining the anatomy of complex
defects; imaging patients with poor echocardiographic windows;1os and
imaging structures difficult to visualise by conventional echocardiography, such
as the pulmonary arteries, pulmonary veins and the aorta. 107,108,109,110
Basic cardiovascular imaging techniques
Due to the rapid motion of the heart relative to the time required to acquire
an image, it is necessary to synchronise the MRI data-aquisition technique to a
physiological trigger. Without such a trigger the image would be blurred
beyond all recognition. The gating trigger normally used is the R wave of the
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patient's ECG.111 ECG-gated MRI can be used to obtain 'dark blood' or 'bright
blood' static or cine images of multiple tomographic slices spanning the heart
and great vessels in three dimensions. Contrast features depend on the
techniques used to send and retrieve MRI signals and can be varied
dramatically without the use of contrast agents. These MRI signal techniques
are called sequences. Cardiovascular images usually are acquired using either
spin-echo sequence or gradient-echo sequence. Spin-echo sequence is
characterised by excellent soft tissue contrast, dark blood and a relatively
slow acquisition time. Conversely, gradient echo sequence is characterised by
poor soft tissue contrast, bright blood and faster acquisition times. Cine
images are possible with either technique. 112
Cine MRI
The anatomy of central pulmonary arteries and veins can be evaluated by
conventional spin-echo magnetic resonance imaging (MRI).n3 Recently
developed techniques of cine MRI and flow mapping, now make it possible to
measure vessel pulsatility and flow.114 MRI could thus provide a noninvasive
means of evaluating pulmonary pathophysiology in pulmonary hypertension. A
noninvasive method of evaluating pulmonary hypertension would be extremely
valuable as invasive procedures carry a higher risk in pulmonary hypertensive
patients, particularly contrast angiography. The attraction of MRI is that it
also allows confirmation of cardiac anatomy and vascular connections, i.e.
information useful for transplant assessment.
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MRI of the pulmonary arteries in pulmonary hypertension
There are a small number of studies which have investigated the MRI features
of pulmonary arteries in pulmonary hypertension. The findings have included
dilated pulmonary arteries, reduced pulmonary arterial pulsatility and altered
flow patterns. 115-117 These initial studies, however, have been on a small
heterogenous population of patients with pulmonary hypertension secondary
to a number of different causes, the majority being mitral stenosis. It is
conceivable that a left to right shunt producing high pulmonary blood flow may
result in different pathophysiological changes in the elastic pulmonary arteries
compared with other causes of pulmonary hypertension.
The aim of this study was to determine the use of MRI in the assessment of
pulmonary hypertension secondary to left to right shunts with reference to the
following:-
1. The safety of the technique and acceptability to patients.
2. MRI features of pulmonary hypertension.
3. Clinical applications of the technique for the assessment of patients with
pulmonary hypertension.




The study was approved by the Hospital Ethics Comittee. The nature of the
study and potential risks of magnetic resonance imaging were explained to the
patients and volunteers and informed consent obtained before commencing the
studies.
The pulmonary arteries of 11 patients, aged 1 8-34, with pulmonary
hypertension secondary to a left to right shunt and established pulmonary
vascular disease were studied by MRI.
Table D shows the clinical characteristics of the patients.
The control group consisted of 6 healthy, non-smoking individuals, aged 25-32.
Magnetic resonance imaging
Magnetic resonance Imaging was performed using a 1.0 Tesla SIEMENS
MAGNETOM 42SP MRI system. Following a fast localising scan, contiguous
7mm-thick, axial slices through the great vessels and heart chambers were
obtained, using an ECG-synchronised, T1 -weighted spin-echo sequence (Fig. 30).
The resultant images helped to establish anatomy and to define subsequent
imaging planes. Further localising scans were then performed in two planes
parallel to the left and right main pulmonary arteries respectively, using an
ECG-synchronised gradient echo cine pulse sequence (Figs. 31a, 31b).
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Table D. Clinical characteristics of patients - MRI
Patient Age Diagnosis PAP SAP PVR
AT 32 Waterston shunt 110/65 110/60 12
DT 34 VSD, Eisenmenger's 105/65 115/65 15
LH 31 VSD, Eisenmenger's 95/60 110/60 12
DB 22 VSD, Eisenmenger's 95/60 115/65 17
SL 35 VSD, Eisenmenger's 90/60 110/65 15
KC 24 AVSD, Eisenmenger's 110/60 120/70 12
LG 22 VSD, Eisenmenger's 110/60 110/60 10
JS 23 PDA (closed) 90/60 100/60 9
JW 19 PDA, Eisenmenger's 110/60 105/60 8
CB 21 VSD, Eisenmenger's 100/65 100/60 10
*DM 28 TGA, VSD, Mustard's 110/65 105/60 12
PAP; pulmonary arterial pressure(mmHg), SAP; systemic arterial
pressure(mmHg), PVR; pulmonary vascular resistance(Wood Units/m2).
VSD; ventricular septal defect, PDA; patent arterial duct, AVSD; atrioventricular
septal defect, TGA; transposition of the great arteries.
*




MRI of thoracic cage and heart - localising scan.
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Figure 31a.
MRI - localising scan of left pulmonary artery.
Figure 31b.
MRI - Localising scan of the right pulmonary artery.
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These images were used to define separate planes which were truly
perpendicular to the two arteries. Further ECG -synchronised, 4mm thick,
gradient echo images were obtained at 50 millisecond intervals throughout the
cardiac cycle in these planes at two locations along the left and right
pulmonary arteries (Figs. 32a, 32b).
The cross-sectional areas at each location of the left and right pulmonary
arteries were measured throughout the cardiac cycle using Region-of-lnterest
software.
Measurements
Regional pulmonary arterial distensibilty was calculated as the percentage of
maximal area attained during systole minus the minimal area during diastole,
divided by the maximal systolic area.
Pulmonary Flow
One further ECG-synchronised acquisition was performed through the mid-
portion of the main pulmonary artery and ascending aorta to obtain velocity
phase maps of blood flow throughout the cardiac cycle, the image intensity of
the velocity phase maps being proportional to the velocity of flow. The
images were displayed in a cine loop which allowed qualitative assessment of
blood flow patterns in the main pulmonary artery and ascending aorta. The
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Figure 32a.
Cine MRI - left pulmonary artery (LPA); aorta (Ao).
Figure 32b.
Cine MRI of right pulmonary artery (arrow); aorta (Ao).
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diameters of the pulmonary artery and aorta were measured above the valve
and an area for each calculated (Figs. 33a,33b). Using dedicated software, the
resultant phase maps and vessel areas were used to calculate cardiac output
from the right and left sides of the heart. The overall shunt or pulmonary to




MRI of pulmonary trunk (p) and branch pulmonary arteries for flow
measurements.




All the patients tolerated the MRI examination well although two felt slightly
claustrophobic. It was possible to obtain satisfactory images of the pulmonary
arteries in all patients except one in whom movement artifact made
interpretation impossible. Unfortunately due to clinical demands on the MRI
equipment used for this study, flow studies were possible on only 7 of the
patients with pulmonary hypertension and 3 of the normal subjects.
In all patients, the MR images clearly delineated the cardiac defects, defined
pulmonary arterial anatomy and size, and allowed measurement of thoracic
cavity size, assessment of systemic venous connections and evaluation of any
spinal scoliosis (Figs. 33a, 34). There was excellent correlation between
diagnosis made at MRI and that made at previous catheterisation. No MRI
examination lasted longer than one hour in any subject and there were no side-
effects.
Pulmonary arterial size
The values for pulmonary arterial luminal area are shown in figure 35. Although
there is a tendency to increased pulmonary arterial size in the group with
pulmonary hypertension when compared with the normal controls, this does
not reach statistical significance (p>0.05, Mann-Whitney U). The size of the
pulmonary artery in normal subjects was remarkably consistent between
subjects but smaller in females than in males.
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Figure 34.
MRI of heart in a 22 year old female showing a ventricular septal defect. The















Comparison of pulmonary arterial diameter between normal subjects
(group 1) and patients with pulmonary hypertension (group 2).
There is a tendency towards increased pulmonary aterial diameter in the
patients with pulmonary hypertension but this does not reach statistical


















Comparison between aortic diameter in normal subjects (group 1) and
patients with pulmonary hypertension (group 2).
There is no difference between the two groups.
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Aortic size
There was no difference in aortic diameter between normals and patients with
pulmonary hypertension (Fig. 36).
Pulmonary arterial distensibily
The change in pulmonary arterial diameter throughout the cardiac cycle in the
patients with pulmonary hypertension and normal subjects is shown in Figure
37. The time taken to peak distention in the normal subjects is approximately
125-1 50ms whereas in the patients with pulmonary hypertension the time to
peak distention is delayed (approximately 225-250ms).
Figure 38 shows the comparison in maximum distensibility between the two
groups. Although there is a tendency towards reduced pulmonary arterial
distensibilty in the population with pulmonary hypertension, the results do not
reach statistical significance (p>0.05, Mann-Whitney-U).
Aortic distensibilty
The results of aortic distensibilty are shown in Figure 39. There is no significant
difference between aortic distensibility in the two groups (p>0.05, Mann
Whitney-U).
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Figure 37.
Pulmonary arterial pulsatility in patients with pulmonary hypertension compared
with normal subjects.
In the normal subjects the time to peak distention is approximately 125-
1 50ms, whereas in the subjects with pulmonary hypertension, the time to peak
distension is delayed (approximately 225-250ms).
(It can also be noted that in the normal subjects, pulmonary arterial diameter




















Comparison of maximum distensibilty ( % change in pulmonary artery size)
between normal subjects (group 1) and patients with pulmonary
hypertension (group 2).
There is a tendency to reduced pulmonary arterial distensibilty in patients



















Comparison between aortic distensibility in normals subjects (group 1) and
patients with pulmonary hypertension (group 2).
There is no difference between the two groups.
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Pulmonary arterial distensibilty and vessel diameter
There is a significant correlation between reduced pulmonary arterial
distensibilty and increased pulmonary arterial diameter (p<0.009, Spearman
Rank Correlation) (Fig. 40).
Shunt Measurements
Table E shows the values for pulmonary and aortic forward and regurgitant
flow, estimated Qp:Qs by MRI and calculated Qp:Qs at catheterisation. The
normal subjects have an expected Qp:Qs of approximately 1:1 as measured by
MRI as does the patient JS, who had undergone surgical closure of shunt
(patent arterial duct) in childhood.
In the patients with uncorrected shunts, there was overall poor correlation
between values of Qp:Qs obtained at cardiac catheterisation and values
obtained at MRI, mainly due to the marked overestimation of Qp:Qs in two
patients by MRI (Table E and Fig. 41).
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Correlation between pulmonary arterial size and distensibility.
The greater the pulmonary arterial diameter, the less the distensibilty
(p<0.009, Spearman Rank Correlation).






























Correlation between shunt calculation of Qp:Qs at MRI and cardiac
catheterisation.
There is good correlation between methods of measurement in 4 patients
but in the other 2 patients, Qp:Qs has been greatly overestimated by MRI,
making overall correlation between the two methods poor.
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Table E. MRI measurements of flow and shunts
Name Ao flow pulm flow Qp:Qs(MRI) Qp:Qs(c
SF(normal) 88 89.3 1.01 -
AH(normal) 83.3 75.9 0.91 -
AS(normal) 77.5 83 1.07 -
CB(PHT) 96.7 86.0 0.89 0.75
*JS(PHT) 80.7 95.5 1.18 1.1
KAS(PHT) 102.4 84.9 0.83 0.75
DB(PHT) 59.4 109.4 1.84 1.16
AT(PHT) 25.3 13.9 0.55 0.68
DT(PHT) 96.5 250 2.59 1.12
SL(PHT) 45.6 43.8 0.96 0.91
Ao flow; aortic flow (mls/s), Pulm flow; pulmonary flow (mls/s), Qp/Qs(MRI);
pulmonary to systemic shunt measured by MRI; Qp/Qs cath; pulmonary to
systemic shunt measured at cardiac catheterisation.
PHT; pulmonary hypertension.
*




The construction of an MRI image is dependent upon a series of acquisitions
gated to the patient's ECG, therefore it is necessary for the patient to remain
still or the effect of movement artifact will obscure images. This was a
problem in two patients scanned who had a persistent cough.
The quality of MRI images is relatively operator independent but for studies to
measure pulmonary arterial diameter it is important to obtain a clear cross
sectional image parallel to each pulmonary artery and it requires a skilled
operator to locate the sites. It is easier to obtain a satisfactory cross-
sectional image of the left pulmonary artery as opposed to the right as the
latter passes posteriorly beneath the aortic arch, whereas the left can be
easily imaged in a saggital section (Figs. 32a, 32b). As measurements of
pulmonary artery size and distensibility are likely to be more accurate and
reproducible if the left pulmonary artery is used, the left was used for
comparisons in this study.
An additional problem in the assessment of pulmonary arterial pulsatility using
cine MRI is the effect of turbulent blood flow within vessels. Areas of turbulent
flow at the edges of vessels result in loss of contrast and thus a tendency to
underestimate vessel area.ne This must be taken into consideration when
measuring luminal area by MRI. The same artifact can lead to poor
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reproducibility of measurements, but if the observers are aware of the
problem, reproducibility is good.
Pulmonary artery dilatation
Postmortem studies on strips of artery show that the elasticity of a vessel
diminishes the more it is stretched from its original size.iis in patients with
left to right shunts increased pulmonary blood volume results in pulmonary
arterial dilatation. As pulmonary hypertension develops, increased
intravascular pressure and resistance contribute further to dilatation of the
pulmonary vessels. The influences of and individual responses to each of these
factors will vary and is likely to explain the wide variation in pulmonary arterial
diameter on MRI in pulmonary hypertensives, which ranged from upper 'normal'
to markedly dilated. This would explain why although there was a definite
trend towards increased pulmonary arterial diameter compared with normals
the values did not reach statistical significance. An additional contributing
factor to lack of statistical significance is the small sample studied.
Pulmonary arterial pulsatility
Our values for pulmonary arterial pulsatility were higher both for normals and
pulmonary hypertensives than values quoted in previous studies. 115-117 in our
study we measured pulmonary arterial luminal area throughout the cardiac
cycle, calculating pulsatility from the maximum and minimum area measured
during one cardiac cycle. All previous studies have calculated pulsatility from a
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single systolic and single diastolic image timed from the patient's ECG. The
latter method would not necessarily give the maximum and minimum luminal
area and it is possible that pulmonary arterial pulsatilty would be
underestimated. This is especially true as the the time to peak distention
appeared to be delayed in pulmonary vascular disease, possibly due to the
increased pulmonary vascular resistance.
Flow Studies
Studies using ultrasound and Doppler to measure cardiac output and calculate
shunts have shown that in adults, measuring the aortic diameter above the
valve tends to overestimate systemic cardiac output as the aorta widens
above the valve."1 ">9 More accurate measurements can be obtained if the
aortic diameter is measured at the level of the valve leaflets or even in the left
ventricular outflow tract.n9 As the difference is less significant in children and
young adults, 120,121 in this study the aortic and pulmonary measurements were
made above the valve. However, the pulmonary arterial dilatation which
occurs in pulmonary hypertension could lead to overestimation of pulmonary
flow.
Shunts
Calculation of Qp:Qs in the normal subjects gave the normal expected values of
1:1. In the subjects with pulmonary hypertension, however, the measurements
of Qp:Qs at MRI correlated well with those at cardiac catheterisation for five
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of the patients but very poorly for the other two patients. There are a
number of factors likely to contribute to inaccuracies in shunt calculation using
the MRI method described above. First, as described above, pulmonary arterial
dilatation secondary to pulmonary hypertension may result in overestimation
of pulmonary flow and right sided cardiac output.122 Second the flow in the
main pulmonary artery is unlikely to be laminar, due to the contribution of flow
from the shunt itself and a variable degree of pulmonary regurgitation which is
common when pulmonary arterial pressures are elevated. Third, pulmonary
regurgitation itself is likely to cause overestimation of effective cardiac output.
Thus, whereas MRI can provide a non-invasive method of estimating cardiac
output in patients without shunts, in those with shunts, values obtained using
the above techniques can be inaccurate.
Conclusions
This study shows that dilated pulmonary arteries, reduced pulmonary arterial
pulsatility and delayed peak distention are features evident on MRI examination
which are consistent with elevated pulmonary arterial pressures and pulmonary
vascular resistance in patients with left to right shunts. MRI is a useful
examination for the confirmation of cardiovascular anatomy, measurement of
thoracic volumes and assessment of spinal scoliosis in patients considered for
cardiopulmonary transplant. Pulmonary arterial studies to measure pulmonary
arterial pulsatilty, size, flow pattern and time to peak distensibility help to
confirm elevated pulmonary vascular resistance but cannot predict severity or
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reversibility. If values of pulmonary vascular resistance and indices of
reversibilty are required cardiac catheterisation is still necessary.
Nevertheless, MRI should not be discarded as a technique for measuring
syystemic to pulmonary shunts and pulmonary vascular resistance. With new
developments in magnetic resonance angiography, it may become possible to
measure pulmonary blood flow in distal vessels. The distal vessels should be
less subject to factors affecting flow measurement in the main pulmonary
arteries. Using measurement of flow in peripheral pulmonary arteries MRI could
become a noninvasive method of measuring systemic to pulmonary shunts and
pulmonary vascular resistance as well as response to pulmonary vasoactive
agents in the future. 123
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CHAPTER 6
MORPHOLOGY OF ELASTIC PULMONARY ARTERIES
A MORPHOMETRIC STUDY
Heath-Edwards Grades
The observation that pulmonary vascular disease was progressive led Heath
and Edwards to grade the morphological changes according to severity (Table
B)9. Following the introduction of routine cardiac catheterisation which allowed
direct measurement of pulmonary arterial pressure, calculation of pulmonary
vascular resistance and assessment of reversibilty, attempts were made to
correlate histological changes with haemodynamic findings. Irreversibilty of
pulmonary vascular resistance appeared to correlate with grade 3-4 on the
Heath- Edwards grades (i.e., the development of complex vascular lesions),
but the overall correlation between Heath-Edwards grades and pulmonary
haemodynamics was generally poor.s in addition it was noted that the
morphological changes of pulmonary vascular disease tended to be patchy,
findings on a single biopsy were not necessarily representative of the the whole
lung and that multiple biopsies were required for an accurate assessment of
pulmonary vascular disease to be made.
Rabinovitch Grades
In 1978 Rabinovitch, Haworth and colleagues took a more morphological
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approach to grading pulmonary vascular diseased They assessed arterial
size, muscularity and alveolar to arteriolar ratio in lung biopsies and developed
a grading system, A to C. This grading system proved to have a good
correlation with haemodynamic data .8,124
Grade A is extension of muscle into smaller and more peripheral arteries than
normal. It is associated with an increase in pulmonary blood flow without an
increase in pulmonary arterial pressure. In grade B, the changes of grade A
are seen but there is also thickening of the medial muscular coat of the small
intra-acinar arteries. If the thickening is mild, it is not associated with elevated
pulmonary vascular pressures, but if the media is greater than twice normal, it
is invariably associated with pulmonary hypertension. Grade A and B are
refinements of Heath-Edwards grade 1 and 2. Grade C represents more
severe disease. In addition to extension of muscle and medial thickening, there
is reduction in the number of small arteries and increase in alveolar to
arteriolar ratio. This change is associated with an elevation in pulmonary
vascular resistance.
Quantitative Morphology of Elastic Pulmonary Arteries
Although it has long been recognised that medial thickening occurs in the larger
elastic pulmonary arteries as well as the muscular arteries, the morphological
changes in the elastic pulmonary arteries have not been quantified. 6,7 Until the
advent of intravascular ultrasound with its ability to image the vessel wall, it
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was only possible to examine the morphology of the vessel wall at post¬
mortem, which is of little use for making decisions about live patients. As it is
now possible to image the vessel wall of elastic pulmonary arteries using
intravascular imaging, it is useful to establish what morphological changes
would be expected on imaging. In addition, if there proved to be a relation
between degree of vessel wall thickness in the elastic pulmonary artries and
severity of pulmonary vascular disease, intravascular ultrasound could
theoretically provide a method of assessing pulmonary vascular morphology in
infants without the need for lung biopsy.
Aims
The aim of this study was to quantify the degree of vessel wall thickening in the
elastic pulmonary arteries in infants under the age of five and to determine:
1. Whether medial thickening of the elastic pulmonary arteries is a feature of
infants with pulmonary hypertension.
2. Whether there is a correlation between degree of vessel wall thickening and
severity of pulmonary vascular disease.
3. Whether the morphological changes in the elastic pulmonary arteries in
pulmonary hypertension would be detectable by intravascular imaging in life.
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METHODS
Specimens of lungs from infants and children who died with pulmonary
hypertension were obtained from the Killingbeck Collection, which consists of
specimens of intact heart and lungs from postmortems performed on patients
with congenital heart disease during the period 1965-1989. Lungs studied
were from infants and children less than age 10 with documented pulmonary
hypertension.
Tables Ft-ssIiow the clinical details of the infants.
Controls
Normal lungs were obtained from infants who died from sudden infant death
syndrome, age 6 months to 2 years, in whom no pathological abnormality was
detected at postmortem.
Preparation of specimens
The cardiac lesion was identified and noted. The lungs were dissected from the
heart at the hilum. 4mm thick slices of lung tissue were cut from the hilum and
periphery from upper and lower lobes of each lung, perpendicular to the line of
the pulmonary vessels. The lingula was avoided as the muscle coat tends to
be thicker in this region of the lung. Several 5pm sections were taken from
each slice. Sections were stained with Haematoxylin and Eosin and Elastin Van
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were assessed. An average of 40 vessels was studied for each specimen of
heart/lungs. The intima was examined for thickening and evidence of
atherosclerosis. Using an image analyser, medial thickness was measured in 4
regions for each vessel and a mean medial thickness for each vessel obtained.
The mean medial thickness was compared against total vessel thickness
(Fig42).
Aorta and pulmonary trunk
The diameters of the aorta and pulmonary trunk were measured. Sections
were then cut from the aorta and pulmonary trunk and the morphology of the
media of the pulmonary trunk was compared to that of the aorta for
'aortification' of the pulmonary trunk.
Peripheral vessels
The peripheral vessels were graded according to the Heath Edwards grades
by an experienced pathologist and compared with the values of medial
thickness for the elastic pulmonary arteries.
Analysis of results
For each specimen, an average medial thickness was obtained for each vessel
size. Vessel sizes were divided into the following groups:-
0.5-1 mm; 1-1.5mm; 1.5-2mm; 2-2.5mm; 2.5-3mm; 3-3.5mm.
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Figure 42.
Method of measuring medial thickness. (x25) (Elastin Van Giesen)
The thickness of the media is measured in four places (mi-4) and an average
medial thickness obtained. The maximum diameter of the vessel is measured
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Figure 43.
Ellipsoid vessel, (x 10) (Haematoxylin and Eosin)
As a result of fixation without injection, vessels can collapse resulting in an
ellipsoid shape. In such cases the maximum vessel diameter was measured
(double headed arrow).
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Patients were divided into the following age groups:-
0-6 months; 6-1 2 months; 1 2-24 months; >24 months.
For each patient age group the range of medial thickness for each vessel size
was plotted on a graph. The results were compared with the values obtained




Number of vessels analysed
An average of 40 vessels was analysed for each patient. The diameter of the
vessels studied ranged from 0.5mm to 3.5mm.
Patient Age
24 (1 3 females) specimens of pulmonary hypertensive lungs and 8 specimens
from children who died from sudden infant death syndrome were studied. The
age at death for the children with pulmonary hypertension ranged from 3
weeks to 9 years, consisting of 7 less than 6 months old, 4 aged 6-1 2 months,
7 aged 12-24 months, and 6 over the age of 2 years. The age of death for
the patients with sudden infant death syndrome ranged from 6-18 months.
Pulmonary arterial pressures
Data from cardiac catheterisation was available for 1 9 patients. In all of these
patients pulmonary arterial pressure was at least half systemic and was
systemic or suprasystemic in 11 patients (Table F).
Cardiac Diagnosis
The main diagnosis of those who died with pulmonary hypertension less than 6
months old was ventricular septal defect, but the older patients tended to
have more complex lesions. All patients except three (marked by * in Table F)
died following palliative or corrective cardiac surgery, most within 24 hours. Of
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the three who died other than following surgery, one (LB) died at the time of
diagnostic cardiac catheterisation, one (NC) died from progressive pulmonary
hypertension and one (JJ) died a sudden death outside hospital.
Drugs
Most of the patients were prescribed Digoxin, Frusemide and Potasium
Chloride. No other medications were documented.
Diameter of pulmonary trunk
All of the patients except one had a degree of dilatation of the pulmonary
trunk when compared with the ascending aorta. In 6 patients the pulmonary
trunk was at least twice the diameter of the ascending aorta. There was no
correlation between dilatation of the pulmonary trunk and age at death or
severity of pulmonary vascular disease. In one patient who had a degree of
subpulmonary stenosis (JR) the diameter of the pulmonary trunk was less than
that of the aorta.
Severity of pulmonary vascular disease
All the infants less than age 6 months had Heath Edwards grade I changes of
pulmonary vascular disease. More severe changes were seen in patients over
the age of 6 months. In patients over the age of 2 years only one had
histological changes less severe than Heath Edwards grade II. This patient had
undergone repair of an atrioventricular septal defect in the first year of life but
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had severe residual mitral regurgitation. None of the infants less than two
years old had evidence of atherosclerosis.
The three patients with the most advanced pulmonary vascular disease
(Heath-Edwards grade IV) all had transposition of the great arteries; two also
had a ventricular septal defect and one (JJ) who had previously undergone a
Mustard's procedure, had severe baffle obstruction of the pulmonary venous
channel. All three patients had evidence of atherosclerosis in the elastic
pulmonary arteries.
Medial thickness
In the normals the range of medial thickness for each vessel size was
remarkably consistent between individuals (fig. 44) but more variable in the
infants with pulmonary hypertension for each age group. The mean medial
thickness for each vessel size, however, was relatively similar between age
groups.
There was no statistically significant difference between the mean values of
medial thickness from normals compared with pulmonary hypertensives (Mann-
Whitney U test). There was, however, an overall increase in medial thickness of
approximately 0.02-0.03mm in vessels of 0.5-1 mm and an increase of 0.03-




















Comparison of mean medial thickness between normal subjects and
patients with pulmonary hypertension.
Between the normals subjects, the values of medial thickness for each
vessel size are remarkably consistent.
In patients with pulmonary hypertension, there is a wide range of medial
thickness for each vessel size in each age group.
In patients with pulmonary hypertension, mean medial thickness is similar
for each vessel size between age groups.
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DISCUSSION
Intravascular ultrasound - histological Correlation
There have been numerous studies attempting to correlate findings on imaging
of vessels by intravascular ultrasound with findings at histology. All these
studies have been of systemic vessels and there are no similar studies of the
pulmonary arteries.37,40,41
There are several reasons why accurate in-vitro histological correlations are
likely to be difficult in the pulmonary arteries. First, it would be difficult to
simulate the effects of adjacent moving lung tissue which are likely to induce
significant artifact and must be considered when imaging intrapulmonary
vessels. In addition it would be difficult to identify the exact site of imaging for
precise histological correlation when imaging vessels within the lung.
Initially, as part of this thesis an attempt was made to carry out in-vitro
histological correlations using fresh pig lungs obtained from the local abbatoir.
Pig lungs were chosen due to the similarity of their pulmonary arteries to
humans'. The lungs were immersed in a water bath and the intravascular
ultrasound catheter introduced directly into the pulmonary tree. Despite
immersion in water, it was impossible to centralise the ultrasound catheter
within the vessels. Due to the catheter's proximity to the vessel wall, problems
of 'ring down' artifact were encountered and the vessel lumen appeared
ellipsoid. In addition, there was poor imaging resolution with the production of
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very poor images which were of insufficient quality for analysis. This is
probably because our method of eliminating air from the pulmonary arteries
was inadequate resulting in poor transmission of ultrasound.
Due to the difficulty in obtaining satisfactory in-vitro correlations it was
decided to proceed first to study postmortem specimens of pulmonary
arteries in patients with pulmonary hypertension to determine whether vessels
accessible to intravascular imaging would have sufficient morphological
changes to be detectable by the technique.
Patient population
Most infants with left to right shunts who develop pulmonary vascular disease
(with the exception of those with atrial septal defects) 125 will have irreversible
changes by the age of 5 years. 16 As the purpose of this study was to
document the morphological changes in the elastic pulmonary arteries in
patients with reversible compared to irreversible pulmonary vascular disease
the age of population examined was 0-10 years. As most other non-cardiac
infant deaths are likely to have some lung pathology, lungs from infants who




All lung specimens studied had been fixed in formalin. The process of tissue
fixation in formalin results in a degree of tissue shrinkage of up to 30%, which
will lead to some degree of underestimation of medial thickness. As all
specimens were fixed in a similar manner they should be subject to similar
degrees of shrinkage artifact. This is supported by the finding that medial
thickness was remarkably consistent between specimens from normal
subjects, however tissue shrinkage must be taken into consideration when
estimating the degree of medial thickness which would be expected in life.
Ideally lungs should be injected with a distending medium at the time of fixation.
Unfortunately none of the lung specimens in this study had been injected at the
time of fixation. As a result the vessels tend to collapse and become more
ellipsoid in shape (Fig 43). This can, of course, introduce errors in measurement
of total vessel diameter and for this reason, in an attempt to overcome this
error, the greatest diameter of each vessel was taken for comparison of
medial to total vessel thickness.
Severity of pulmonary vascular disease
Irreversible pulmonary vascular disease is believed to occur between grade III-
IV by the Fleath-Edwards grading system. In this series of patients, the
youngest with grade III changes was aged 18 months and the youngest with
grade IV changes was aged 20 months. In a series of 90 patients,
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Rabinovitch, Haworth and colleagues23 found that progression of pulmonary
vascular disease was more aggressive for certain cardiac defects, particularly
transposition of the great arteries with ventricular septal defect. Certainly the
patients with the most severe pulmonary vascular disease in this series all had
a diagnosis of transposition of the great arteries, but it must also be taken
into account that these patients were all older than 20 months.
Interestingly the patient (NC) who died from progressive pulmonary
hypertension despite medical therapy had only grade I pulmonary hypertensive
changes. The medial thickening was, however, very marked in both the
muscular and elastic pulmonary arteries. This suggests that severe muscular
hypertrophy without occlusive disease may be sufficient for irreversible
pulmonary hypertension, possibly due to marked vasoconstriction.
Medial Thickness
Although the measurements of medial thickness for different vessel sizes were
remarkably consistent between normal subjects, medial thickness in the
pulmonary hypertensives was more variable. In addition, there was no direct
correlation between the degree of medial thickening in the elastic pulmonary
arteries and the severity of pulmonary vascular disease as determined by the
Heath Edwards grades.
There are a number of factors which will influence overall medial thickness in the
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elastic pulmonary arteries in patients with pulmonary hypertension. First, vessel
dilatation occurs to a variable degree in pulmonary hypertension. This will
affect the ratio between total vessel diameter and medial thickness and
stretching of the vessel wall may result in a degree of medial thinning. Second,
it is believed that high shearing stresses from elevated pulmonary flow and
pulmonary arterial pressures result in endothelial damage. Platelets adhere to
the damaged endothelium releasing mitogens which stimulate the proliferation
of medial smooth muscle cells.126 There are likely to be individual differences in
the response of medial smooth muscle cells to mitogens. It is possible that
patients with increased risk of platelet aggregation, including those with
cyanosis and polycythaemia are at risk of developing more aggressive disease.
This may partly explain why patients with transposition of the great arteries
appear to develop more aggressive pulmonary vascular disease.
In the patients with pulmonary hypertension, although there was a wide range
of values of medial thickness for each vessel size in each age group, the mean
medial thickness for each vessel size was relatively similar between age
groups. Compared with normals, there was an overall increase in medial
thickness of approximately 0.2-0.3mm in the 0.5mm elastic pulmonary arteries
and 0.03-0.05mm in the 3mm elastic pulmonary arteries (i.e. vessels accessible
to current intravascular catheters). When shrinkage artifact is considered, this
is a maximum increase in medial size by approximately 0.06-0.07mm in the
3mm vessels. Unfortunately this is outwith the resolution of the 30 MHz
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intravascular transducers and thus it would be unlikely that intravascular
ultrasound could differentiate this degree of medial thickening from normals.
Conclusions
From the above findings and the findings on intravascular ultrasound,
morphological changes which are evident in the elastic pulmonary arteries in
pulmonary hypertension include medial thickening, vessel dilatation, intimal
thickening and atherosclerosis. The presence of atherosclerosis is associated
with more advanced stages of pulmonary vascular disease and such changes
are likely to be evident on intravascular ultrasound. Changes of medial
thickening and vessel dilatation are too variable to be of predictive value in
indicating the severity of pulmonary vascular disease and unlikely to be of a
magnitude to be detectable by intravascular ultrasound. In conclusion, imaging
of vessel wall morphology in life by intravascular ultrasound in patients with
pulmonary hypertension may help to confirm advanced disease but cannot
differentiate between less severe pulmonary hypertensive disease when the




The main problem with attempting to study pulmonary vascular disease in life
is that the significant changes mainly occur in the small resistance vessels of
less than 500pm in diameter. Although there is no doubt that morphological
changes and physiological changes occur in the larger elastic pulmonary
arteries, as has been shown in this study, these changes do not directly reflect
the severity of pulmonary vascular disease.
Although intravascular ultrasound has been used to study vessel morphology in
the systemic circulation, when imaging the pulmonary arteries with
intravascular ultrasound it is difficult to identify the three layers of the vessel
wall, possibly partly because the vessels studied are elastic pulmonary arteries
with an elastin rich media. In patients with longstanding advanced pulmonary
vascular disease atherosclerotic lesions can be identified at post mortem and
in life by intravascular ultrasound. In infants with earlier disease, the intima of
the elastic pulmonary arteries is smooth and the vessel wall thickness largely
reflects the thickness of the media. Medial thickening is evident in the elastic
pulmonary arteries in infants and children with pulmonary hypertension but this
is of a degree which is outwith the resolution of a 30MHz intravascular
ultrasound transducer. It is unlikely, therefore, that such an increase in medial
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thickening could be differentiated from normal by intravascular imaging. Even if
it could, the clinical significance is limited as there is no direct relation to
severity and reversiblity of pulmonary vascular disease.
The limited application of intravascular ultrasound in identifying morphological
changes in pulmonary hypertension is disappointing but is of less importance
as early surgery for infants with left to right shunts becomes normal practice.
Advances in cardiac surgery together with improvements in cardioprotection
and cardiopulmonary bypass have made it possible to perform corrective
surgery even in very young infants, prior to the development of advanced
pulmonary vascular disease and morphological assessment of pulmonary
vascular disease is therefore less frequently required.
A subject now attracting greater interest than morphology is pulmonary
reactivity and response to vasoactive agents in life. Post-operative pulmonary
hypertension following cardiac surgery in neonates and infants remains a
difficult problem for intensivists and cardiologists, and although the
introduction of Nitric Oxide has enhanced the management of this problem a
greater understanding of the nature of the condition as well as a method of
identifying patients at risk is needed. This is true also for other conditions
where pulmonary hypertension is poorly understood and controlled, including
altitude sickness and primary pulmonary hypertension.
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The study of pulmonary reactivity ideally should be performed in life.
Intravascular ultrasound gives excellent definition of the vessel lumen and offers
a unique method of studying larger vessels. If combined with Doppler,
simultaneous study of the smaller resistance vessels should be possible.
Intravascular ultrasound is relatively straightforward to learn and perform. It
can be performed with minimal morbidity either at the time of cardiac
catheterisation or surgery.
Magnetic resonance imaging is limited as a method of studying vascular
reactivity as the technique is still confined to imaging extraparenchymal
arteries, i.e large elastic pulmonary arteries. Unfortunately using current
imaging techniques, measurements of pulmonary flow and pulmonary to
systemic shunts can be inaccurate due to a number of confounding effects,
including pulmonary regurgitation and vessel dilatation. Nevertheless, advances
in magnetic resonance angiography raise the possibility that in the future flow
in the intraparenchymal pulmonary vessels could be studied, potentially
providing a noninvasive method of studying pulmonary vascular resistance in
life.
In conclusion therefore, current MRI techniques have little to offer in the study
of pulmonary vascular disease and pulmonary vascular reactivity. Intravascular
ultrasound allows both imaging of vessel lumen diameter and vessel wall
morphology. The morphological changes which are detectable on intravascular
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imaging in pulmonary hypertension tend to be in severe disease and are not
likely to affect clinical management. Intravascular ultrasound does, however,
provide a unique method of studying pulmonary reactivity in life. If combined
with Doppler, it could provide a useful method of studying vascular reactivity in
life, not only in the pulmonary tree but also in other vessels.
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